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The nonsense mediated mRNA decay (NMD) pathway is a conserved 
posttranscriptional mRNA decay pathway that functions to destabilize a variety of 
naturally occurring target mRNAs. The NMD pathway functions in all eukaryotes and 
regulates a significant portion of the transcriptome. It is thought that this regulation is 
critical as inhibition of NMD leads to physiological and developmental defects in all 
organisms and in the case of more complex organisms, lethality. It is predicted that 
overexpression of NMD pathway target genes leads to these defects in NMD mutants. 
Despite the critical nature of this pathway, little is know about how NMD functions in a 
developmental and physiological context, including which target genes are most critically 
regulated by NMD and how the overexpression of these targets may mediate the NMD 
mutant phenotype. To address this knowledge gap, we first use two genome-wide 
techniques to identify and characterize the kinds of transcripts targeted by NMD in the 
context of an intact metazoan, Drosophila melanogaster. We then examine more closely 
the function of one of these target genes, Gadd45, and find that overexpression of this 
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 Two well-studied aspects of regulated gene expression are the mechanisms of 
transcriptional activation and transcriptional repression (Shandilya and Roberts, 2012). 
While transcriptional control does indeed contribute to the regulation of many genes, the 
steady-state level of any given mRNA is a combination of not only its transcription rate, 
but also the rate of RNA degradation. In many cases, gene expression is primarily 
regulated by modulation of mRNA decay. This process is executed by a number of 
pathways, some of which function in the decay of all transcripts, while others, such as the 
nonsense mediated mRNA decay (NMD) pathway, target a select set of transcripts 
(Garneau et al., 2007; Kervestin and Jacobson, 2012). Through its ability to regulate the 
expression of these specific transcripts, NMD has important cellular and organismal 
functions (Hwang and Maquat, 2011).  
NMD is a conserved cellular process that functions in all eukaryotes examined. 
This pathway is named for its ability to target and degrade mRNA alleles harboring 
nonsense mutations while passing over cognate wild-type messages (Chang et al., 2007). 
However, NMD can also degrade other RNAs, including certain transcripts that contain 
no mutation whatsoever (Dahlseid et al., 1998). The trans-acting factors that execute 
NMD are generally required for normal development and physiology, suggesting that the 
negative regulation of native RNAs targeted by the NMD pathway is a critical feature of 
eukaryotic biology (Behm-Ansmant et al., 2007). However, the full extent of NMD-
mediated regulation, in particular which target genes are most critically regulated by 
NMD, remain unknown.   
To analyze the role of NMD in development and physiology in vivo, we have 
exploited genetic techniques available for the fruit fly, Drosophila melanogaster. This 
has allowed us to address many outstanding questions such as 1) Are there specific 
NMD-target genes that mediate the NMD loss-of-function phenotype?, 2) What portion 
of the transcriptome is regulated by NMD?, 3) What cis-acting features of native target 
mRNAs allow for recognition by the NMD machinery?, and 4) Does NMD have any 
tissue-specific roles?  
 
Introduction to NMD 
The term “nonsense mediated decay” was coined in 1993 by Allan Jacobson to 
describe the phenomena in which decay rates of nonsense-mutation bearing transcripts 
are increased over those of wild-type transcripts (Belasco, 1993). In general, this 
accelerated decay leads to lower steady-state levels of mutant transcripts and thus fewer 
molecules of encoded polypeptide (Chang et al., 2007). NMD was first described in S. 
cerevisiae (Losson and Lacroute, 1979) but has since been shown to operate in all 
eukaryotes examined, including humans (Maquat et al., 1981). In certain cases, NMD 
function has been demonstrated by direct measure of the differential RNA stability 
between wild-type and nonsense-mutant transcripts (Losson and Lacroute, 1979; Maquat 
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et al., 1981). In other cases, NMD has been demonstrated to function indirectly, through 
the steady-state accumulation of target transcripts when NMD activity is inhibited.  
NMD is executed by a suite of evolutionarily conserved trans-acting proteins that 
function together in an “NMD pathway” (Behm-Ansmant et al., 2007). The best-studied 
NMD pathway genes are the Upfs (for Up-frameshift suppressor, (Culbertson et al., 
1980)) and the Smgs (for Suppressor with morphogenic effects on genitalia, (Hodgkin et 
al., 1989)). Upf1, Upf2, and Upf3 were discovered as required for nonsense-transcript 
turnover in yeast (Leeds et al., 1991, 1992), and homologues with equivalent roles were 
subsequently identified in all eukaryotes. Suppressor screens in C. elegans identified the 
homologues of all three Upf genes called smg-2, smg-3, and smg-4, for Upf1, Upf2, and 
Upf3, respectively (Hodgkin et al., 1989). In addition, four other genes, smg-1, smg-5, 
smg-6, and smg-7 were identified (Cali et al., 1999; Hodgkin et al., 1989). These latter 
Smg genes are found throughout metazoa, although plants may have a distant homologue 
of Smg7 and Smg1 . More recently discovered NMD pathway genes include Smg8 and 
Smg9, identified as binding partners of SMG1 (Yamashita et al., 2009), and Smgl1 and 
Smgl2, which are required to degrade an NMD-sensitive transgenic reporter gene 
(Longman et al., 2007). These factors are poorly conserved, and their roles in NMD are 
less well understood. 
 
Mechanisms of NMD targeting 
NMD substrate recognition is thought to function through the ability of the NMD 
machinery to recognize inherent differences between translation termination that occurs 
at nonsense, or premature, termination codons (PTCs) caused by nonsense mutations, and 
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termination at natural termination codons (NTCs) (Ghosh et al., 2010; Kervestin and 
Jacobson, 2012; Kervestin et al., 2012). Consistent with this notion, NMD is translation 
dependent and the application of pharmacological inhibitors that inhibit translation 
elongation or initiation block NMD and stabilize PTC-bearing transcripts (Carter et al., 
1995; Zhang et al., 1998). Additionally, ribosomal toeprinting analysis, a technique that 
maps sites of ribosomal pausing during translation, reveals unreleased pausing at PTCs in 
nonsense mutation containing mRNAs that are targeted by NMD (Amrani et al., 2004). 
Pausing at PTCs is thought to be indicative of inefficient release of ribosomal subunits 
following termination (Amrani et al., 2004), a process that is so rapid at NTCs that no 
pausing can be detected (Cui et al., 1995; Pisarev et al., 2010). 
Following the aberrant termination that occurs at PTCs, NMD targeting is 
initiated through binding of the central trans-acting effector, UPF1, an ATP-dependent 
RNA helicase whose helicase function is required for NMD (Chamieh et al., 2008). UPF1 
connects translation termination to NMD by interacting with both the terminating 
ribosome and the target RNA (Ivanov et al., 2008). The helicase domain of UPF1 directly 
interacts with the target mRNA (Bhattacharya et al., 2000), while other regions of the 
protein bind the ribosome indirectly via interactions with the eukaryotic release factors, 
eRF1 and eRF3 (Ivanov et al., 2008). Formation of the UPF1/release factor complex is 
stimulated by UPF1 binding to UPF2 (Mendell et al., 2000), as well as by interactions 
between UPF2 and UPF3 (Chamieh et al., 2008; Maderazo et al., 2000). In metazoans, 
UPF1 activity is further regulated by the SMG proteins, with UPF1 being phosphorylated 
by the phosphatidylinositol 3-kinase-related kinase (PIKK) family protein, SMG1 
(Yamashita et al., 2001). Along with UPF1 and the release factors, SMG1 forms a stable 
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complex, termed the SURF complex (for SMG1, UPF1 and release factors) (Kashima et 
al., 2006). Formation of the SURF complex promotes UPF1 phosphorylation and is 
thought to be a prerequisite for NMD function (Yamashita et al., 2009). Phosphorylated 
UPF1 can then bind SMG6 (Okada-Katsuhata et al., 2012), an endoculease, which has 
been shown to cleave target mRNAs near the PTC (Eberle et al., 2009; Huntzinger et al., 
2008). To initiate dephosphorylation of UPF1, phosphorylated UPF1 recruits a complex 
of the proteins SMG5 and SMG7, which in turn recruit the phosphatase PP2A (Anders et 
al., 2003). Dephosphorylation by PP2A is thought to facilitate dissociation of NMD 
proteins and the targeting of new mRNAs, allowing for recycling of NMD proteins onto 
new target mRNAs.  
In all eukaryotes, decay of NMD targets is driven by recruitment of the decapping 
complex, consisting of DCP1 and DCP2, to the 5’ end of the transcript (Lejeune et al., 
2003; Mitchell and Tollervey, 2003). The decapping complex removes the 5’ 7-
methylguanosine cap of the mRNA, exposing the 5’ phosphate to the ubiquitous 
cytoplasmic 5’ to 3’ exonuclease, XRN1 (Arribas-Layton et al., 2013). Additionally, in 
metazoans, decay is initiated by endonucleolytic cleavage of target mRNAs by SMG6 
(Gatfield and Izaurralde, 2004; Huntzinger et al., 2008), which exposes an XRN1-
sensitive 5’ phosphate and a 3’ hydroxyl, which is susceptible to the cytoplasmic 
exonuclease, the exosome (Houseley et al., 2006).   
 
Recognition of substrate RNAs 
One of the most intriguing aspects of NMD function is how the NMD machinery 
is able to distinguish target from nontarget mRNAs. This problem has mostly been 
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studied by examining the difference between wild-type and nonsense-bearing NMD-
targeted transcripts. These studies have lead to two nonexclusive models that explain how 
the NMD pathway might recognize nonsense transcripts. One of these models, the “faux 
3’ UTR” model, is based primarily on work in yeast. Work in mammalian cell culture has 
lead to the “exon junction complex (EJC)” model (Amrani et al., 2004)(Figure 1.1).  
The faux 3’ UTR model is based on the observation that the 3’ UTRs of nonsense 
transcripts are inherently different and longer than those of the cognate wild-type 3’ UTR. 
This model states that under normal circumstances, translation termination and ribosomal 
reloading onto the 5’ end of the transcript are promoted by specific interactions that occur 
between the natural 3’ UTR/poly A tail, or associated proteins, and the terminating 
ribosome. These interactions do not take place when translation terminates at a PTC, 
which leads to inefficient ribosome dissociation and the ability of the NMD machinery to 
initiate decay. Proteins associated with mRNAs, known as ribonuclear proteins (RNPs), 
such as poly A binding protein (PABP), associate with the poly A tail. PABP has been 
shown to promote efficient translation termination via interactions with the release 
factors, interactions that are mutually exclusive with UPF1 binding (Amrani et al., 2004; 
Kervestin et al., 2012). Thus, the faux 3’ UTR model states that RNPs (such as PABP) 
compete with UPF1 for binding release factor, and when the interaction with UPF1 
dominates, NMD is initiated. Consistent with this, when the long(er) 3’ UTRs of 
nonsense transcripts are experimentally shortened, bringing the poly A tail into closer 
proximity with the termination codon, transcripts are rendered insensitive to NMD 
(Eberle et al., 2008). Similarly, long 3’ UTRs that are NMD-sensitive can be rendered 
insensitive by the experimental introduction of double-stranded foldback motifs that also 
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bring the poly A tail into closer proximity with the termination codon (Eberle et al., 
2008). 
From work in mammalian cell culture, a different model has been put fourth that 
emphasizes the importance of a specific kind of RNP. In all metazoans, an assembly of 
proteins, known as the exon junction complex (EJC), associates with mRNA within 25 nt 
upstream of exon-exon junctions concurrent with splicing in the nucleus (Le Hir et al., 
2000). During the first, or “pioneer” round of translation, EJCs are removed or remodeled 
(Gehring et al., 2009; Sato and Maquat, 2009). Under the EJC model, if a ribosome 
encounters a termination codon with an EJC positioned downstream, NMD is triggered 
(Nagy and Maquat, 1998). This model is supported by evidence in mammals that NMD 
can only occur during the pioneer round of translation (Hwang et al., 2010; Maquat et al., 
2010). Furthermore, for many mammalian genes, NMD does not target transcripts in 
which the PTC is in a terminal exon. This is also found for PTCs that are positioned in 
the penultimate exon, but are still downstream of the site of EJC deposition. Also 
supporting this model is the observation that a majority of wild-type transcripts harbor 
NTCs in the terminal exon and are not targeted (Nagy and Maquat, 1998). Moreover, the 
NMD factor UPF3 is a component of the EJC, and UPF2 also associates with the EJC 
once the transcript is exported to the cytoplasm (Chang et al., 2007).  
While the exact proposed mechanisms appear different, the faux 3’ UTR and EJC 
models essentially state that local RNP interactions around the site of translation 
termination are used by the NMD machinery to detect termination at PTCs. In addition, 
NMD in mammals is not exclusively driven by detection of downstream EJCs. NMD can 
also be initiated by long 3’ UTRs even in the absence of splice junctions (and thus no 
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downstream EJCs). These observations imply that downstream EJCs are not absolutely 
necessary to initiate NMD in mammals and therefore, the EJC may represent a 
mechanism that potentiates NMD, but is not the underlying trigger mechanism.    
Another sequence feature thought to help specify NMD targets is the so-called 
downstream sequence element (DSE), located in 3’ UTRs. The DSE was identified in 
yeast as a 12-base pair cis-acting sequence that, when deleted, partially stabilizes certain 
NMD target transcripts (Peltz et al., 1993). DSEs may stimulate NMD by recruiting the 
protein HRP1, which has been shown to bind both DSEs and UPF1 in vitro (González et 
al., 2000). In this way, HRP1 acts analogously to EJCs to stimulate NMD when 
translational termination occurs at a PTC (González et al., 2000). DSE-like sequences 
have not been reported in metazoans, although it is possible that other similar cis-acting 
features exist.      
 
NMD pathway function is essential for normal  
development and physiology 
The conservation of NMD pathway genes throughout eukaryota suggests that 
these genes perform essential functions. The requirement for NMD genes could be 
explained by two general models. First, NMD genes could be required because function 
of the NMD pathway itself is necessary for development and viability (Hwang and 
Maquat, 2011; Palacios, 2013). Conversely, genes involved in the NMD pathway could 
have requirements in non-NMD functions. In support of the first model is the observation 
that loss of individual NMD genes leads to remarkably similar phenotypes in the same 
organism (Table 1.1). In S. cerevisiae, disruption of any Upf gene results in cold 
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sensitivity (Altamura et al., 1992). In S. pombe, loss of the Upf genes leads to sensitivity 
to oxidative stress (Rodríguez-Gabriel et al., 2006). In C. elegans, mutations in any of the 
seven Smg genes gives rise to abnormal genital development (Cali et al., 1999; Hodgkin 
et al., 1989). In Drosophila, null mutants of Upf1 and Upf2 have an identical lethal phase, 
with the majority of larvae dying in the second larval instar (Chapin et al., 2014). In 
zebrafish, morpholino-mediated depletion of Upf1, Upf2, Smg6, or Smg5 lead to greater 
than 80% reduction in viability at 5 days post fertilization as well as impaired 
development of the brain and eye and abnormal somites (Wittkopp et al., 2009). In mouse, 
loss of Upf1 (also called Rent1), Upf2, or Smg1 results in inviability by embryonic day 
7.5, 9.5, and 12.5, respectively (McIlwain et al., 2010; Medghalchi et al., 2001; 
Weischenfeldt et al., 2012). In Arabidopsis, Upf1 and Smg7 are both required during 
early embryogenesis (Riehs et al., 2008; Yoine et al., 2006). Moreover, in mutants in 
which NMD is only partially inactive, the strengths of other phenotypes are also reduced. 
For instance, Drosophila Smg1 mutants have both a mild NMD defect and are mildly 
affected in terms of overall viability, while null alleles of Smg6 impart an intermediate 
defect in both NMD and viability (Frizzell et al., 2012). Taken together, these data 
suggest it is the function of NMD itself that is required for normal development and 
physiology in eukaryotes. 
Through analyses in many different organisms, the NMD pathway has been 
implicated as functioning in numerous biological processes. Perhaps the most well 
studied is regulation of the cell cycle. In Drosophila, siRNA-mediated knockdown of any 
of the six NMD factors in S2 cell culture results in arrest at the G2/M transition of the 
cell cycle (Rehwinkel et al., 2005). Mosaic analysis reveals that loss of Upf1 or Upf2 in 
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follicle cells results in a cell-autonomous proliferation defect that can be recued by 
expression of the apoptosis inhibitor, p35, suggesting that NMD-deficient cells activate 
pro-apoptotic pathways (Avery et al., 2011). Mosaic analysis in the eye suggests the 
proliferation defect of NMD-deficient cells is caused by an inability to effectively 
compete with wild-type cells in the same field. Cell/cell competition is defined as the 
cell-cell interactions that sense metabolic state relative to neighboring cells (Johnston, 
2009). In a competitive context, cells that have a weakened metabolic state are eliminated 
through apoptosis. These states are communicated via signaling cues that either promote 
apoptosis in “losing” cells or compensatory growth in “winning” cells. A defect in 
cell/cell competition, as opposed to a defect in overall cell viability, can be revealed using 
a special type of mosaic analysis, the GMR:hid technique (Stowers and Schwarz, 1999). 
Using this technique, NMD mutant cells can be generated while simultaneously 
eliminating competing wild-type cells through forced induction of apoptosis. In this 
context, NMD mutant clonal patches expand to sizes much larger than those generated 
using standard clone-making techniques in which wild-type cells are still present 
(Metzstein and Krasnow, 2006). These results suggest that a functioning NMD pathway 
is required to promote a metabolic state that allows cells to effectively compete, rather 
than NMD being absolutely required for proliferation or viability.  
In mammalian cell culture models, NMD genes are required for efficient 
progression through S-phase, suggesting a role in DNA synthesis (Azzalin and Lingner, 
2006). In mice, conditional disruption of Rent2 (Upf2) in the hematopoietic lineage 
results in a loss of proliferative cells, but has no effect on differentiated, postmitotic cells. 
Furthermore, murine blastocysts mutant for Rent1 (Upf1) or Smg1 demonstrate 
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widespread activation of apoptosis, as measured by TUNEL staining (McIlwain et al., 
2010; Medghalchi et al., 2001). Part of the dependence on NMD for proper cell cycle 
control could be related to a defect in telomere maintenance, as has been demonstrated in 
human cells silenced for NMD components (Azzalin et al., 2007). In S. cerevisiae, NMD 
components have also been shown to have an epistatic relationship with the telomere 
maintenance genes Yku70 and cdc13, suggesting that this aspect of NMD function is 
conserved (Addinall et al., 2008, 2011).  
NMD has also been shown to have specific functions in neuronal tissue. From 
observations in mammal cell culture (Giorgi et al., 2007) and Drosophila (Barbee et al., 
2006), NMD components are found associated with dendritic mRNPs; complexes of 
mRNA and protein found in dendrites. In neurons, dendritic mRNPs function in the 
transport of specific mRNAs to synapses, where the cargo mRNA undergoes local 
translation.  When NMD is inhibited in rat PC-12 cells, via depletion of the EJC factor 
eIF4III, there is an increase in the amplitude of mini excitatory postsynaptic currents 
(mEPSC), which is indicative of an increase in the numbers of excitatory receptors found 
in postsynaptic regions of dendrites (Giorgi et al., 2007). This modulation of receptor 
levels may be related to the function of the immediate early gene, arc, which is a natural 
target of NMD. Arc mRNA is a dendritic mRNP cargo message, and ARC protein has 
been shown to modulate receptor levels as part of the process of long-term potentiation at 
synapses (Plath et al., 2006). NMD has also been shown to function at the synapse in 
Drosophila, as mutations in Smg1 (also known as nonC), Upf2, or Smg6 all lead to 
abnormal morphology at the neuromuscular junction (NMJ) and impaired synaptic 
vesicle cycling (Long et al., 2010).     
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NMD has also been shown to have a functional role in brain development in 
mammals. In the brains of mice, Upf1 mRNA is negatively regulated by expression of a 
microRNA, miR-128, that binds in the 3’ UTR of Upf1. miR-128 expression increases 
over the course of murine embryonic development such that NMD activity in the brain is 
gradually repressed (Bruno et al., 2011). This increase in miR-128 activity over 
development is in agreement with data from cell culture-based studies, which suggest 
expression of miR-128 (and thus regulated suppression of NMD) is required for proper 
neuronal differentiation (Bruno et al., 2011). NMD has also been shown in mammals to 
function in the regulation of axon guidance. NMD components are found in the growth 
cones of various classes of murine neurons, and disruption of NMD results in disruption 
of axon trajectories during development (Colak et al., 2013). The role of NMD in this 
process may be related to an mRNP cargo message, robo3.2, a natural NMD target (by 
virtue of a retained intron that creates a PTC in this isoform) that is locally translated in 
growth cones (Colak et al., 2013). Evidence from human studies also suggests a role for 
NMD in the central nervous system. Loss of function mutations in one of the two 
homologues of Upf3, Upf3B (or Upf3X), are associated with two forms of X-linked 
mental retardation, Lujan-Fryns syndrome and FG syndrome (Tarpey et al., 2007). Both 
these syndromes are characterized by intellectual deficits, implying that NMD could also 
play a functional role in human neurodevelopment.    
 
Two models to explain eukaryotic dependence on NMD 
The precise mechanisms of the dependence on NMD for normal development and 
physiology in eukaryotes are not well understood. However, NMD has been shown in 
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many cases to target and degrade various naturally occurring RNAs (“native” RNAs), in 
addition to its classically studied targets, nonsense-mutation containing transcripts. It is 
likely that regulation of native RNAs is essential for the various biological processes that 
rely on NMD. These native target genes fall into two general categories. The first type is 
“junk” RNA, i.e, RNAs that do not code for any obviously functional protein nor carry 
out any other productive function in the cell. For instance, NMD has been shown to 
degrade unprocessed mRNAs in the cytoplasm, intragenic transcripts, and transcripts of 
viral origin (Neu-Yilik et al., 2004). In contrast, NMD has also been shown to directly 
target fully processed and otherwise fully functional mRNAs. Thus, it appears that NMD 
can act as a cellular surveillance pathway that degrades unproductive junk RNAs and as a 
specialized posttranscriptional regulatory pathway with specific target genes. Based on 
these ideas, two general models have been developed to describe the in vivo function of 
NMD: The “Vacuum Cleaner” model represents the surveillance capabilities of NMD, 
whereas the “Swiss Army Knife” model emphasize the role of NMD in targeted 
posttranscriptional gene regulation (Neu-Yilik et al., 2004). The vacuum cleaner model 
states that NMD is essential due to its surveillance capabilities. Therefore in NMD 
mutants, organisms succumb to a buildup of unproductive transcripts. The Swiss Army 
Knife model states that NMD is vital due to its role in negative regulation of specific, 
wild-type transcripts, and in NMD mutants it is the stabilization of these specific mRNAs 
that interferes with normal development and physiology.  
Chapters 3 and 4 of this dissertation describe experiments that functionally test 
both the vacuum cleaner and Swiss Army Knife models of NMD function in Drosophila. 
A prediction of the latter model is that NMD mutants succumb to overexpression of a 
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small number of direct NMD targets. To test this prediction, we conducted a rescue 
screen described in Chapter 3 that was designed to identify genes whose overexpression 
suppresses an NMD mutant phenotype. In addition, the Swiss Army Knife model predicts 
that NMD may have tissue-specific functions due to the targeting of specific transcripts 
with spatially restricted expression patterns. According to the vacuum cleaner model, 
NMD would be required in all tissues at all times in development, as presumably all 
tissues produce aberrant transcripts. To test this distinction, we performed a tissue-
specific rescue screen, described in Chapter 4, to look for tissues where NMD function is 
sufficient for organismal viability.  
 
Identification of NMD pathway target mRNAs 
The identification of native target genes is critical to understanding why 
organisms rely on a functioning NMD pathway. As described by the vacuum cleaner 
model, NMD targets many types of aberrant RNAs. For instance, incompletely spliced 
transcripts that escape into the cytoplasm could contain PTCs, thus triggering NMD when 
such transcripts undergo translation. Indeed, such transcripts were among the first native 
RNAs to be identified as targets (He et al., 1993). In addition, transcripts emanating from 
nonfunctional programmed rearrangement (such as in the TCR locus in mammalians) 
(Wang et al., 2002), unproductively spliced ribosomal proteins (Mitrovich and Anderson, 
2000), noncoding rRNAs (Marquardt et al., 2011), intragenic transcripts originating from 
read-through (Thompson and Parker, 2007), transcripts of viral or transposon origin 
(Guan et al., 2006), genes that undergo aberrant 3’ UTR length extension (Muhlrad and 
Parker, 1999), and genes that undergo leaky scanning (Welch and Jacobson, 1999) have 
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all been identified as NMD targets.  
Another large class of unproductive native transcripts that appear to be under 
regulation by NMD are those created through the process of alternative splicing. 
Alternative splicing is a broadly employed mechanism to control gene expression and 
increase transcript diversity that relies on differential splicing to control the relative 
amounts of various RNA isoforms transcribed from a single locus (Ben-Dov et al., 2008). 
In humans and Drosophila, 85% and 50% of genes are estimated to undergo alternative 
splicing, respectively. In certain cases, alternative splicing is utilized to regulate the 
overall abundance of a single productive mRNA isoform, rather than to produce multiple 
productive forms. By controlling the relative levels of the productive versus unproductive 
forms, overall levels of the productive form can be regulated. When gene expression is 
controlled in this way, it is referred to as regulated unproductive splicing and translation 
(RUST) (Lareau et al., 2007a), and NMD is predicted to degrade unproductive isoforms 
that generate PTCs (Lewis et al., 2003; McGlincy and Smith, 2008). For example, 50% 
of transcripts from the mammalian FGFR2 gene contain a PTC but are degraded to 
undetectable levels in the presence of a functioning NMD pathway (Jones et al., 2001). A 
similar situation also occurs in the case of the Drosophila sex determination gene tra, 
which undergoes an alternative splicing event in females such that the major isoform 
contains several PTCs creating a NMD-sensitive substrate (Longman et al., 2007; 
Metzstein and Krasnow, 2006).   
Other types of native targets exist that contain special sequence features or utilize 
special types of regulation that lead to targeting by the NMD pathway. For example, 
genes that use +1 frameshifting to regulate protein expression (Gatfield and Izaurralde, 
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2004), transcripts containing uORFs (Welch and Jacobson, 1999), genes with unusually 
long 3’ UTRs (Kebaara and Atkin, 2009), and in mammals, genes with the NTC not 
positioned in the terminal exon (Mendell et al., 2004) have all been shown to sensitize 
transcripts to NMD. For example, genes like Oda utilize a +1 frameshift as part of normal 
regulation (Ivanov et al., 1998). In this case, full-length protein is only produced when a 
ribosomal frameshift to the +1 reading frame is induced by high levels of cytoplasmic 
polyamines. When this shift does not occur, the result is early termination, which creates 
PTCs and renders the transcript NMD-sensitive (Gatfield and Izaurralde, 2004). Another 
feature that has been shown to sensitize native transcripts to NMD is a long natural 3’ 
UTR (Kebaara and Atkin, 2009). Such 3’ UTRs are downstream from NTCs, but are 
longer, on average, than typically found in 3’ UTRs. Targeting of these transcripts by the 
NMD pathway is thought to work in a manner similar to that of nonsense targeting, in 
that the long natural 3’ UTR is recognized as aberrant, and therefore termination at the 
NTC initiates decay.  
 
Genome-wide approaches to studying NMD targeting 
While various attributes of NMD targets have been shown to bestow NMD-
sensitivity, none are completely predictive of whether any particular mRNA is targeted, 
with some transcripts containing what appear to be NMD-sensitizing features, yet these 
transcripts are not destabilized by NMD. This inconsistency suggests our current 
knowledge of NMD target gene recognition is incomplete. Thus, the goal of identifying 
all native NMD target genes cannot by met with a purely predictive bioinformatic 
approach. Therefore, assays have been developed that rely on various functional 
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definitions of NMD targets, and when coupled with technologies that query genome-wide, 
they can identify native targets across the transcriptome.           
The most conceptually straightforward and most commonly used technique to 
identify NMD targets is the identification of genes that are upregulated in NMD-defective 
organisms or cells. This approach relies on using transcript upregulation as a proxy 
readout for stabilization, as direct RNA targets should be stabilized when NMD is 
inhibited, allowing steady-state levels of these transcripts to increase. This type of 
analysis is also useful for revealing the full extent of NMD-dependent gene expression 
since upregulation in an NMD-mutant background does not solely identify direct targets 
of NMD. For instance, levels of secondary targets, which are positively regulated by 
direct targets, should also be upregulated when NMD is inhibited. Using upregulation in 
an NMD-mutant background will also identify genes that are dependent on the function 
of trans-acting NMD factors, but not on the process of NMD itself. However, the 
inclusion of this type of false positive can be minimized by studying sets of genes 
regulated by multiple NMD factors. Genetic mutation in (or silencing of) any given NMD 
component generally results in the upregulation of about 10% of the transcriptome, as has 
been demonstrated in yeasts (He et al., 2003; Matia-González et al., 2013), plants 
(Rayson et al., 2012), C. elegans (Ramani et al., 2009), Drosophila (Metzstein and 
Krasnow, 2006; Rehwinkel et al., 2005), zebrafish (Wittkopp et al., 2009), mouse 
(Weischenfeldt et al., 2008), and human cells (Mendell et al., 2004; Yepiskoposyan et al., 
2011). In a few studies, sets of genes have been defined that are upregulated in multiple 
backgrounds lacking NMD. In Arabidopsis, Upf1, Upf3, and Smg7 negatively regulate a 
shared set of 206 transcripts (0.9% of all genes). In S. cerevisiae strains carrying 
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mutations in any of the three Upf genes, 10 to 12 % of expressed genes show differential 
upregulation, which represents a set of 792 genes (11.6% of expressed transcripts) (He et 
al., 2003). In Drosophila S2 cells, six well-studied NMD components, Upf1, Upf2, Upf3, 
Smg1, Smg5, and Smg6, regulate a common set of 184 genes, representing 3.4% of 
detectable transcripts (Rehwinkel et al., 2005). Finally, inhibition of Upf1 or Smg6 in 
HeLa cells results in the upregulation of a common set of 158 genes (Yepiskoposyan et 
al., 2011).   
A second method used to enrich for direct targets of NMD relies on techniques 
that can resolve expression changes between multiple mRNA splice isoforms from a 
single locus. The logic of this technique is based on the assumption that any secondary 
transcriptional effects caused by NMD disruption will alter the expression of all isoforms 
equally, whereas for direct targets, alternatively spliced forms will be differentially 
affected. Not only is isoform-specific analysis a useful way to measure direct targeting by 
NMD, but it can also be used to estimate the overall role of NMD in the decay of 
transcripts produced by RUST. Estimates from C. elegans indicate that 25% of all AS 
events introduce a PTC and that NMD can target a significant portion (59%) of these 
PTC-bearing, AS-generated mRNAs (Barberan-Soler et al., 2009). In Drosophila, a much 
smaller portion of AS events were identified as NMD-regulated (43 confirmed events 
from a possible 2244) (Hansen et al., 2009). This disparity between the worm and fly 
might be due to stricter statistical cutoffs used in these two analyses or the vastly larger 
sample size used in the Drosophila experiment. An important consideration when 
interpreting the results of experiments examining AS is that NMD has been shown to 
regulate the expression of splicing factors (Lareau et al., 2007b; Morrison et al., 1997; Ni 
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et al., 2007). Therefore, it is possible that NMD could indirectly influence the relative 
expression levels of splice isoforms, which would result in the inclusion of false positives 
when assigning whether a specific isoform is directly targeted or not.       
Other methods to detect direct NMD targeting use biochemical techniques, such 
as crosslinking-immunoprecipitation (CLIP) coupled with array-based or deep 
sequencing technology to identify transcripts bound by NMD factors on a genome-wide 
scale (Hurt et al., 2013; Johansson et al., 2007; Matia-González et al., 2013). Such studies 
were based on initial observations from C. elegans that suggested that SMG-2 (UPF1) 
preferentially associates with PTC-harboring transcripts when compared to wild-type 
transcripts (Johns et al., 2007). By inference, native transcripts that are enriched for 
bound UPF1 are likely to be directly targeted. This has been shown to be the case in yeast 
(Johansson et al., 2007), where TAP-tagged UPF1 is found bound to 44% of genes that 
are upregulated in Upf1 mutants, suggesting these transcripts represent true direct targets. 
A similar analysis in murine embryonic stem cells (mESCs) found that 35% of genes 
upregulated following siRNA depletion of Upf1 showed enrichment of Upf1 binding 
(Hurt et al., 2013). UPF1 binding to substrate mRNAs is not, however, an absolute means 
of target identification as UPF1 has also been shown bound to nontargeted substrates 
(Hogg and Goff, 2010; Zünd et al., 2013).  
Still other methods to identify direct targets genome-wide rely on the decay 
kinetics of NMD target transcripts, in that direct NMD targets decay at a faster rate 
compared to nontargets. In a simple application of this principle, timecourse expression 
profiling has been performed on wild-type and Upf1Δ yeast cells following inhibition of 
transcription using thiolutin (Guan et al., 2006). This analysis revealed that, of genes 
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upregulated upon NMD inhibition, 46% (279/607) show slower decay rates. Interestingly, 
of the 279 genes identified as direct targets using this method, only 108 (39%) are part of 
the core set of direct NMD targets identified using UPF1-binding and a reactivation assay 
(described below) to define direct targets (Johansson et al., 2007). Another example of an 
analysis based on altered target stability in NMD mutants has been performed using the 
BRIC-seq technique to monitor turnover of mRNAs (Tani et al., 2012b). In HeLa cells 
silenced for Upf1, 23% of the upregulated genes were shown to also be stabilized 
compared to controls (Tani et al., 2012a).  
 A different technique that also takes advantage of the decay kinetics of NMD 
target genes uses acute activation of the NMD pathway, rather than acute inhibition of 
transcription, to reveal decay kinetics (Johansson et al., 2007; Maderazo et al., 2003). A 
“reactivation” assay can be executed by expressing a gene product in a cognate NMD 
mutant and monitoring expression levels of putative target genes over a short time course. 
Using this technique, it is possible to distinguish direct from indirect targets. Direct 
targets of NMD respond quickly to this reactivation and thus decay quickly, whereas 
levels of indirect targets take longer to respond. This technique has been used in S. 
cerevisiae, in conjunction with UPF1 CLIP analysis, to assess the degree of direct 
targeting (Johansson et al., 2007). Of the 792 genes upregulated at steady state in Upf1 
mutants, 230 (30%) demonstrated both acute reactivation and enrichment of UPF1 
binding. In Chapter 2 of this thesis, we adapt this method for use in whole Drosophila 
larvae, the first time such a method has been deployed in metazoa.  
  
20
Features and functions of the NMD-regulated transcriptome 
Using the techniques described above, several studies have sought to describe 
NMD targets both in terms of the structures or cis-targeting features that make transcripts 
susceptible to NMD and the functions of those target genes. These studies have used 
various model organisms and different experimental paradigms, making direct 
comparisons difficult. Nonetheless, a few general themes have emerged. While single 
NMD genes are required for proper expression of about 10% of the transcriptome, 
anywhere from 60% to less than 10% appear to be directly regulated. This proportion of 
direct targets to total indirect targets generally tracks with the complexity of the organism. 
In S. cerevisiae, the vast majority of expression level changes in the three Upf mutants 
result in up, but not downregulation (85 to 96%). This indicates that secondary target 
effects on overall gene-expression levels, which are predicted to result in equal levels of 
up and down regulation, are minimal. Furthermore, pairwise comparisons of the genes 
upregulated between the three NMD mutants indicate a minimum correlation coefficient 
of 0.96, indicating that the three Upf genes in yeast have a very minimal impact on gene 
expression outside of their roles in NMD. Additionally, 29% of the 792 genes 
upregulated in the three Upf mutants are identified as targets in two completely different 
assays, the Upf1 binding assay and a Upf2 reactivation assay, described earlier.  
In more complex organisms, directly regulated NMD targets represent a smaller 
portion of the transcriptome found upregulated by inhibition of particular NMD factors. 
For instance, in HeLa cells, just 23% of genes upregulated upon Upf1 knockdown are 
found to be stabilized by the same treatment. As direct targets of NMD are predicted to 
be stabilized by inhibition of NMD, of which only 23% of upregulated genes are direct 
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targets, indicates that the majority of gene expression changes that occur following Upf1 
silencing are indirect. This small portion of direct targets could be explained by the 
greater complexity of mammalian physiology compared to yeasts, and thus a greater 
influence of NMD on secondary targets. Additionally, when compared to yeast, there is 
generally a greater portion of genes that are downregulated by NMD disruption in 
mammals, again suggesting that more secondary targets exist in mammals.        
Interestingly, some of the techniques used to detect genome-wide NMD targets  
have generated counterintuitive results. For instance, NMD substrates have been 
identified that behave like direct substrates in kinetic assays, but are not upregulated in 
steady state (Johansson et al., 2007; Matia-González et al., 2013; Tani et al., 2012a). In 
yeast, 55% of genes that decay upon Upf2 reactivation are not upregulated at steady state. 
In HeLa cells, 90% of the transcripts that are stabilized in Upf1-silenced cells are not 
upregulated at steady state. These results could imply that a majority of direct NMD 
substrates are subject to additional regulation that can renormalize expression levels 
when NMD activity is compromised. An alternative hypothesis is that NMD, or NMD 
components, can also function as transcriptional activators. Thus, when NMD is inhibited, 
these transcriptional functions are also disrupted, along with the defects associated with 
transcript decay. These effects would cancel each other out, leading to little change in 
steady state levels. Such a model is supported by evidence that other mRNA decay 
factors are required for transcription of the very transcripts that these factors are known to 
target (Haimovich et al., 2013; Sun et al., 2013). As NMD factors are known to have 
nuclear functions (Brogna, 1999; Varsally and Brogna, 2012) and have been shown to 
influence the kinetics of events that occur cotranscriptionally at sites of target gene 
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transcription (de Turris et al., 2011), it is possible that NMD factors could also have some 
influence on the transcription rate of native decay targets.     
Another recurring theme of NMD-targeting is the observation that NMD pathway 
genes are often NMD targets themselves. In both Drosophila and humans, Smg5 and 
Smg6 are direct NMD targets (Chapin et al., 2014; Huang et al., 2011; Rehwinkel et al., 
2005; Yepiskoposyan et al., 2011). In plants, Smg7 and Upf3 are targets of the NMD 
pathway (Rayson et al., 2012). These observations suggest that autoregulation of NMD 
may be an important aspect of overall NMD function.   
 
Gene ontology and cis-acting features of NMD targets 
In all organisms, analysis of the ontological categories enriched in genes regulated 
by NMD encompass a diverse spectrum of functionality, suggesting NMD-mediated 
regulation could be involved in many cellular processes. In S. cerevisiae, types of 
functional categories of NMD targets include genes involved in telomere maintenance, 
thiamine biosynthesis, splicing, nitrogen metabolism, and DNA repair . In S. pombe, 
genes that are induced upon nitrogen starvation are also regulated by NMD. In 
Drosophila, NMD appears to regulate an especially diverse array of biological processes 
including defense response, amino acid metabolism, signal transduction, development, 
and cell adhesion. In mammals, NMD targets are enriched in genes involved in cell death 
and amino acid metabolism (McIlwain et al., 2010; Mendell et al., 2004). In plants, NMD 
targets genes involved in the transcriptional response to pathogens (Rayson et al., 2012).  
Taken together, these data suggest that NMD could potentially regulate numerous 
biological processes; however, certain processes stand out. For instance in Drosophila, 
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the observation that many NMD target genes have known cell cycle functions is 
consistent with other observation that NMD mutants are defective in cell cycle 
progression. However, a direct link between specific substrate RNAs and the 
physiologically relevant functions of NMD has rarely been demonstrated. NMD mutants 
in S. pombe are stress sensitive, and double mutants for NMD genes and the direct target 
gene rex2 partially rescue the sensitivity to oxidation observed in NMD single mutants 
(Matia-González et al., 2013). In S. cerevisiae, the magnesium transporter Alr1 is 
upregulated in NMD mutants, leading to an increase in intracellular magnesium that 
decreases the fidelity of translation termination (Johansson and Jacobson, 2010). In 
Arabidopsis, where NMD mutants have been shown to upregulate genes involved in the 
response to pathogen infection (Rayson et al., 2012), double mutants for Upf1 and PAD4, 
(a transcription factor critical for the transcriptional response to pathogens, but not a 
direct NMD target) rescued some of the NMD-dependent defects, indicating that NMD 
mutants may suffer from an overactive immune response (Riehs-Kearnan et al., 2012). 
Chapter 3 describes a screen that was designed to identify specific target genes that 
mediate the critical functions of NMD in Drosophila.      
Genome-wide analysis of NMD targeting can also be used to test hypotheses 
about and uncover the cis-acting sequence features that allow native genes to be 
recognized by NMD. For instance, in most organisms, genes with long 3’ UTRs and 
uORFs, both of which have been shown to sensitize transcripts to NMD, are enriched in 
lists of NMD-targeted genes. When the link between alternative splicing and NMD is 
examined, many targeted isoforms include PTCs, suggesting that NMD does 
preferentially target such transcripts. Additionally, genes that contain 3’ UTR introns are 
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targeted in mammals (Mendell et al., 2004). These data demonstrate that genes 
containing such features are preferentially targeted by NMD. However, there are many 
genes in all experimental systems that contain no predicted NMD-sensitizing features, yet 
appear to be directly targeted. For instance, in S. cerevisiae, only one-third of targets 
contain known NMD-stimulating features, such as uORFs or long 3’ UTRs. Moreover, 
many genes that do contain such sensitizing features are not targeted by NMD, 
suggesting yet undiscovered transcript features that are required to sensitize transcripts to 
regulation by NMD, or alternatively, sequences that protect transcripts from NMD are 
present.      
 
NMD and human disease 
The study of NMD has often centered around its role in human disease. It is 
estimated that 11% of all inherited human genetic disorders are due to nonsense 
mutations (Mort et al., 2008). Therefore, it is possible that NMD is involved in the 
surveillance of all these disease-associated mRNAs. Supporting this conclusion is the 
observation that for several well-characterized disorders, polarity of the PTC (generally 
positioned more 5’ or more 3’) can drastically change the severity and the Mendelian 
inheritance pattern (dominant or recessive) of the associated disorder (Bhuvanagiri et al., 
2010). These observations are interpreted as a differential sensitivity of the PTC-bearing 
transcript to NMD, for example, if the PTC is positioned in a way that can be interpreted 
by the NMD machinery as premature. Examples of this PTC positional polarity include 
well studied diseases such as spinal muscular atrophy, muscular dystrophy, and cystic 
fibrosis.  
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In a few cases, the positional effects of PTC localization have been conclusively 
shown to be caused by NMD. For example, familial β-thalassemia can be inherited in 
either a dominant or recessive form, both of which can be caused by nonsense mutations 
in the β-globin gene. Alleles positioned towards the 5’ end of the gene create a sensitive 
NMD substrate, and mutant transcripts are degraded. These alleles confer a recessive 
mode of inheritance as the wild-type copy in heterozygotes compensates for the nonsense 
allele. However, PTCs positioned in the 3’ terminal exon are not detected by NMD, 
presumably because they lack downstream EJCs, and the mutant transcript is found at 
wild type levels (Hall and Thein, 1994). These alleles show a dominant mode of 
inheritance, which stems from a buildup of truncated β-globin protein in erythrocytes, 
and the mutant protein causes a dominant interfering effect on the production of 
hemoglobin, which overwhelms the cells proteolytic machinery resulting in cell death 
(Thein et al., 1990).  
 Because NMD can potentially influence the clinical symptoms of many genetic 
diseases, there has been considerable effort to devise pharmacological interventions to 
manipulate the function of the NMD pathway (Durand et al., 2007; Keeling et al., 2013; 
Kuzmiak and Maquat, 2006; Martin et al., 2014). For instance, if NMD can be inhibited 
in cases where decay of mutant transcripts eliminates the expression of (partially) 
functional truncated peptides, it may help to rescue some of the clinical symptoms 
associated with disease. In a proof-of-principle study, inhibition of NMD was shown to 
rescue some of the cellular phenotypes associated with mutations in collagen VIα2, 
which results in the development of Ullrich Disease (Usuki et al., 2006). In this case, 
pharmacological inhibition of NMD using caffeine or wortmannin (inhibitors of Smg1), 
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or gene silencing of NMD components in patient-derived fibroblasts resulted in rescue of 
the expression levels of collagen VI. Demonstrating the physiological relevance of this 
rescue, NMD inhibition also rescued the weakened cell/ECM interactions typical of 
Ullrich patient fibroblast (Usuki et al., 2006).  
 
Summary 
Throughout this thesis, the many genetic techniques available in Drosophila are 
used to study two main questions surrounding NMD: what are the direct native targets of 
the NMD pathway and what are the functional consequences of this targeting? Chapter 2 
describes the development of an NMD reactivation assay for use in whole Drosophila 
aimed at discovering novel in vivo direct targets. In Chapter 3, the functional 
consequences of targeting a potentially important direct target of NMD, Gadd45, are 
analyzed. In Chapter 4, a screen aimed at the identification of tissues where NMD 
function is most important for viability is described. This screen suggests that NMD 
function in neuronal tissue may be sufficient for viability in Drosophila. Taken together, 
our data suggest a model where NMD regulates a small number of target genes, including 
Gadd45, in a way that is essential for viability, and that function of NMD in neuronal 
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ABSTRACT Nonsense-mediated messenger RNA (mRNA) decay (NMD) is a mRNA degradation pathway that
regulates a signiﬁcant portion of the transcriptome. The expression levels of numerous genes are known to be
altered in NMD mutants, but it is not known which of these transcripts is a direct pathway target. Here, we
present the ﬁrst genome-wide analysis of direct NMD targeting in an intact animal. By using rapid reactivation
of the NMD pathway in a Drosophila melanogasterNMDmutant and globally monitoring of changes in mRNA
expression levels, we can distinguish between primary and secondary effects of NMD on gene expression.
Using this procedure, we identiﬁed 168 candidate direct NMD targets in vivo. Remarkably, we found that 81%
of direct target genes do not show increased expression levels in an NMD mutant, presumably due to
feedback regulation. Because most previous studies have used up-regulation of mRNA expression as the
only means to identify NMD-regulated transcripts, our results provide new directions for understanding the
roles of the NMD pathway in endogenous gene regulation during animal development and physiology. For
instance, we show clearly that direct target genes have longer 39 untranslated regions compared with non-
targets, suggesting long 39 untranslated regions target mRNAs for NMD in vivo. In addition, we investigated
the role of NMD in suppressing transcriptional noise and found that although the transposable element Copia







Steady-state messenger RNA (mRNA) expression levels are controlled
by a balance of de novo transcription and transcript degradation.
Nonsense-mediated mRNA decay (NMD) is a degradation mechanism
that functions to target mRNAs in a translation-dependent manner
(Kervestin and Jacobson 2012). The machinery required to execute
NMD is evolutionarily conserved (Behm-Ansmant et al. 2007b), with
three core proteins, Upf1, Upf2, and Upf3, found throughout the
eukaryotes. Four other well-characterized NMD factors, Smg1, Smg6,
and the paralogous proteins Smg5 and Smg7, are thought to function
as regulators of the core components and are required for NMD in
many, but not all organisms (Behm-Ansmant et al. 2007b; Riehs et al.
2008; Lloyd and Davies 2013). NMD function is required for viability
in complex organisms, including Drosophila (Metzstein and Krasnow
2006), zebraﬁsh (Wittkopp et al. 2009), mammals (Medghalchi et al.
2001; McIlwain et al. 2010; Weischenfeldt et al. 2012), and plants
(Kerényi et al. 2008). In contrast, in simpler organisms, including
Saccharomyces cerevisiae (Leeds et al. 1991), Schizosaccharomyces
pombe (Mendell et al. 2000), and Caenorhabditis elegans (Hodgkin
et al. 1989), NMD is not required for viability. However, loss of
NMD pathway function leads to stress sensitivity in yeasts (Leeds
et al. 1991; Rodríguez-Gabriel et al. 2006) and abnormal morphogen-
esis in C. elegans (Hodgkin et al. 1989), indicating that NMD does have
important biological roles in these organisms. Loss-of-function muta-
tions in different NMD genes lead to a similar spectrum of defects
within an organism (Hodgkin et al. 1989; Rehwinkel et al. 2005;
Metzstein and Krasnow 2006; Wittkopp et al. 2009; Avery et al.
2011; Frizzell et al. 2012), suggesting that, although a number of NMD
pathway components may function in NMD-independent processes
Copyright © 2014 Chapin et al.
doi: 10.1534/g3.113.009357
Manuscript received November 8, 2013; accepted for publication January 14, 2014;
published Early Online January 15, 2014.
This is an open-access article distributed under the terms of the Creative
Commons Attribution Unported License (http://creativecommons.org/licenses/
by/3.0/), which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
Sequence data from this article have been deposited with the Sequence Read
Archive under nos. SRR896609, SRR896616, SRR503415, SRR503416.
Supporting information is available online at http://www.g3journal.org/lookup/
suppl/doi:10.1534/g3.113.009357/-/DC1
Arrays have been submitted to the GEO database at NCBI as series GSE47979.
1These authors contributed equally to this work.
2Present address: Department of Epidemiology, The University of Texas MD
Anderson Cancer Center, Houston, TX 77030.
3Corresponding author: 15 N 2030 E, Salt Lake City, UT 84112.
E-mail: markm@genetics.utah.edu
Volume 4 | March 2014 | 485
42
   
(Azzalin and Lingner 2006; Roberts et al. 2013), NMD is in itself
required for proper development and physiology.
It is not known why organisms rely on a functional NMD pathway
for viability. The best-known targets of the NMD pathway are
transcripts harboring premature termination codons (PTCs). One
possibility is that all organisms contain a background load of PTC-
containing transcripts, arising from inheritance or by sporadic errors
in transcription or splicing, and that the NMD pathway is required to
eliminate these erroneous mRNAs to maintain normal cellular
function (Neu-Yilik et al. 2004). An alternative model is that NMD
regulates a set of endogenous, error-free transcripts and this regu-
lation is required for development and viability. One observation in
support of this latter model is that loss of NMD pathway function
results in changes in the expression levels of many endogenous genes
(He et al. 2003; Mendell et al. 2004; Rehwinkel et al. 2005; Metzstein
and Krasnow 2006; Weischenfeldt et al. 2008; Ramani et al. 2009;
Wittkopp et al. 2009; Yepiskoposyan et al. 2011; Rayson et al. 2012).
These studies have found that up to 15% of all genes in diverse
organisms may be under constitutive negative regulation by the
NMD pathway. On the basis of these analyses, a model has emerged
wherein NMD-mutant phenotypes, including lethality, are due to
misregulation of speciﬁc native targets (Hwang and Maquat 2011;
Palacios 2013). However, it is unclear how many genes that are
misregulated in NMD mutants are directly targeted by the NMD
pathway vs. those genes that are indirectly targeted, and which direct
NMD targets are responsible for the organismal defects observed in
NMD mutants. Distinguishing between direct and indirect targets is
thus important to understanding NMD mutant phenotypes, as well
as the mechanisms by which the NMD machinery recognizes en-
dogenous substrates.
In a few studies, investigators have sought to identify direct NMD
targets by using a number of different approaches. Splicing-sensitive
microarrays have been used to identify instances of differential change
in expression of speciﬁc mRNA isoforms when NMD is inhibited
(Barberan-Soler et al. 2009; Hansen et al. 2009). Because changes in
transcription after NMD disruption are expected to affect all splice
isoforms equally, differential NMD-sensitivity of different splice iso-
forms indicates direct targeting. However, NMD has been shown
to functionally regulate splicing factors (Barberan-Soler et al. 2009;
Weischenfeldt et al. 2012), so relative changes in isoform expression
may not only be due to direct targeting. Another approach to assess
direct NMD targeting is to identify which RNAs are bound to the
critical NMD factor Upf1, because direct NMD targets are known to
show enriched Upf1 binding (Johansson et al. 2007; Hurt et al. 2013;
Matia-González et al. 2013). Such binding does not, however, un-
equivocally identify NMD substrates, as Upf1 also binds many non-
NMD targets (Hogg and Goff 2010; Zünd et al. 2013).
Another genome-wide technique that can be used to identify
NMD targets is analysis of mRNA decay rates, with the assumption
that direct NMD targets will show increased stability upon inhibition
of NMD. Using such an approach, Guan et al. (2006) compared rates
of mRNA decay between Upf1+ and Upf1D yeast strains after treat-
ment with the transcriptional inhibitor thiolutin. This analysis
revealed that 220 of 616 genes (36%) that are up-regulated in Upf1D
mutants had slower decay than that observed in the Upf1+ back-
ground. Recently, Tani et al. (2012a) globally measured mRNA decay
rates in HeLa cells depleted of Upf1 by siRNA knockdown. In this
case, the authors used the RNA sequencing-based BRIC-seq technique
(Tani et al. 2012b), which allows for monitoring of decay without the
use of transcriptional inhibitors. They found that the mRNAs of 76 of
324 genes (23%) that were signiﬁcantly up-regulated after Upf1 knock-
down were stabilized in the absence of Upf1. Thus, both these studies
conclude that the majority of genes up-regulated in the absence of
a functional NMD pathway are not directly targeted by the NMD
machinery.
A ﬁnal approach that has been used to identify direct NMD-
pathway substrates is the use of an NMD “reactivation” assay (Maderazo
et al. 2003; Johansson et al. 2007). This assay, developed in yeast cells,
uses an inducible system to rapidly restore levels of an NMD gene in
a cognate NMD mutant background. Before reactivation, levels of both
direct and indirect NMD-regulated genes accumulate. After reactiva-
tion, direct targets are expected to be rapidly degraded whereas levels of
secondary targets will decrease only after direct target levels are nor-
malized. Thus, by monitoring mRNA levels over a reactivation time
course, direct and secondary NMD targets can be distinguished. Using
this approach in S. cerevisiae, Johansson et al. (2007) found that 427 of
792 (54%) of genes that are overexpressed in an NMD mutant appear
to be direct targets, as deﬁned by the reactivation assay, and conversely,
68% of direct targets are overexpressed in NMD mutants.
No study has yet been performed to experimentally distinguish
direct from indirect NMD targets in an intact, multicellular organism.
Here, we describe the use of larval Drosophila melanogaster to char-
acterize NMD targeting in such a setting. First, we used RNA sequenc-
ing to identify transcripts with altered expression levels in animals
mutant for the NMD gene Upf2. Next, to identify direct targets, we
adapted the yeast NMD reactivation assay so as to distinguish rapidly
degrading direct targets from slower responding indirect targets. To
this end, we reintroduced Upf2 into Upf2-deﬁcient larvae and identi-
ﬁed transcripts that were depleted rapidly on a genome-wide scale. We
ﬁnd that a minority of genes up-regulated in an NMD mutant appear
to be direct targets. Strikingly, we also ﬁnd that a majority of directly
targeted genes do not show increased expression at steady state when
the NMD pathway is inactivated. Bioinformatic analysis of our can-
didate direct targets reveals that these genes have on average signiﬁ-
cantly longer 39 untranslated regions (UTRs) then nontarget control
transcripts, suggesting that a long 39 UTR is a primary mechanism of
NMD targeting in intact Drosophila, as has been proposed based on
cell culture experiments (Behm-Ansmant et al. 2007a). We also use
our reactivation assay to demonstrate that an observed increase in
retrotransposon expression, known to occur in NMD mutants, is
likely due to indirect effects of NMD pathway disruption.
MATERIALS AND METHODS
Fly stocks and genetics
All ﬂy stocks were reared according to standard protocols (Sullivan
et al. 2000). Balancers used were FM7i, Act5C:GFP, and FM7c. The
mutant NMD alleles are described in Metzstein and Krasnow (2006).
Upf225G is on the chromosome y w Upf225G FRT19A and for a control,
we used y w FRT19A (Xu and Rubin 1993). The heat-shock GAL4 is
w!; P{w[+mC]=GAL4-Hsp70.PB}89-2-1 (Bloomington Drosophila
Stock Center #1799) (Roman et al. 2000).
Construction of the UAS-Upf2 transgene
The long Upf2 coding sequence plus 39 UTR (4767 bp) required
a multistep procedure to generate the full-length rescuing transgene.
First, we used the primer pairs Upf2xF1 and Upf2xR1 to amplify
a 140 bp 59 fragment and the primer pair Upf2xF2 and Upf2xR2 to
amplify a 500 bp 39 fragment at the end of the Upf2 39 UTR, using
the full-length Upf2 cDNA RE04053 (Stapleton et al. 2002) as a tem-
plate. The two fragments were then joined (based on overlapping
sequences present in Upf2xR1 and Upf2xF2) using Upf2xF1 and
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Upf2xR2. The resulting product was TOPO-TA cloned in pCR4
(Invitrogen, Carlsbad, CA) and sequenced to conﬁrm that no errors
were introduced during polymerase chain reaction (PCR) ampliﬁca-
tion. We then replaced the middle section of this clone (using nat-
urally occurring NheI and BstBI restriction sites present in the Upf2
gene) with a 4.3-kb NheI/BstBI fragment from RE04053. Finally, we
subcloned this full-length cDNA using NotI and SmaI sites present
in the primers, into NotI/StuI-digested pUAST (Brand and Perrimon
1993). Note, this procedure removes the SV40 39 UTR present in
pUAST, which is itself sensitive to NMD-mediated degradation
(Metzstein and Krasnow 2006). Flies were transformed with the
pUAST construct using standard P-element2mediated transgene-
sis. Transgenic injections were performed by BestGene Inc. (Chino
Hills, CA). Primer sequences listed in Table S4.
RNA isolation and cDNA preparation
Whole animals or cells were homogenized in Trizol (Invitrogen) and
total RNA extracted using a standard three-phase chloroform
technique (Chomczynski and Sacchi 1987). RNA was puriﬁed and
concentrated using the RNeasy column (QIAGEN Inc., Gaithersburg,
MD), including an on-column treatment with DNase I. Random
decamer-primed cDNA was prepared using M-MLV reverse transcrip-
tase (RNase H+) as part of the RETROscript kit (Ambion, Austin, TX).
For each reverse transcription reaction, 10 mg of input RNA was used
to aid in comparisons of absolute abundance between samples.
RNA sequencing
For each replicate (two control and two mutant), we collected 11 male
larvae of genotype y w FRT19A/Y (control) or y w Upf225G /Y (mutant)
in a 0- to 4-hr time period past the L2/L3 molt. Male larvae where
identiﬁed by sorting using the FM7i, Act5C:GFP balancer (for
Upf225G), or by morphological criteria (for the control). Total RNA
was isolated using Trizol/chloroform and quality assessed using a 2100
Bioanalyzer (Agilent, Santa Clara, CA). cDNA synthesis and sequenc-
ing was performed by Cofactor Genomics (St. Louis, MO). In brief,
rRNA was removed from the sample using RiboMinus Eukaryote Kit
(Invitrogen), 1 mg of this puriﬁed RNA was fragmented using reagents
in the Illumina RNA-seq kit (Illumina, San Diego, CA), then reverse
transcribed using random hexamers and Superscript II (Invitrogen,
Carlsbad, CA), and the second strand synthesized with DNA Pol I and
RNase H. To construct a sequencing DNA library, the double-
stranded cDNA was blunted, tailed with an A base, ligated with
paired-end adaptors in the Illumina RNA-seq kit (Illumina, San
Diego, CA), and size selected on a polyacrylamide gel. Sequencing
was performed on an Illumina GAIIx platform, according to man-
ufacturers protocols.
Quantiﬁcation of RNA-seq data
We used the USeq package to identify differentially expressed genes
(Nix et al. 2008). In brief, USeq counts the number of reads aligned to
each annotated gene and uses the DESeq algorithm to prioritize genes
according to their P-values of being differentially expressed (Anders
and Huber 2010). Internally, a negative binomial distribution is adop-
ted by DESeq to model the discrete read counts in each sample and
account for the overdispersion of the coverage data.
Reactivation and microarray experiments
RNA was isolated, as described previously, from the following
genotypes: Upf225G/FM7i, Act5C:GFP; UAS-Upf2/hsp70-GAL4 (ex-
perimental), and Upf225G/FM7i, Act5C:GFP; hsp70-GAL4/+ (con-
trol). Library construction and hybridization were performed at
the GNomEx core at the Huntsman Cancer Institute at the University
of Utah. cDNA was generated in a poly dT-primed reverse-transcription
(RT)-PCR using MMLV-RT. Labeled cRNA was generated by incorpo-
rating cyanine 3-CTP or cyanine 5-CTP into a T7 RNA polymerase
reaction using the cDNA as template. Hybridization was performed
on an Agilent Drosophila 44K array using a Agilent SureHyb hybrid-
ization oven. Hybridized chips were scanned using a Agilent G2505C
Microarray Scanner and signal processing accomplished with Agilent
Feature Extraction software, v 10.5. Stepwise normalization was per-
formed with the Limma package in R (Smyth and Speed 2003), including
background signal correction, normalization within microarrays, and
normalization between microarrays.
Identiﬁcation of reactivation targets
To identify high conﬁdence reactivation targets, we ﬁrst applied
a number of ﬁltering steps to the data obtained from our microarray
time course. We ﬁrst eliminated genes from the analysis that displayed
expression changes of more than 20% from the preheat shock time
point to the 4-hr time point in control experiment (without cDNA).
This was found to be primarily due to low absolute expression levels.
Next, we veriﬁed that leaky expression from the Upf2:cDNA transgene
did not lead to rescue of NMD target gene levels by comparing ex-
pression between the experimental and control samples at the prior-
to-heat shock time point, and removed any genes that differed in
expression by more than 50% between the two condition. In this
analysis, we did not observe consistent rescue of target genes. Finally,
those genes which did not have high-conﬁdence annotations in FlyBase
were also removed.
We then used criteria similar to those used by Johansson et al.
(2007) to identity reactivation targets in the ﬁltered set. Our pri-
mary criterion was a decrease in expression of at least 1.8-fold over
the 4-hr time course in the animals carrying the rescue cDNA and
that this decrease in expression differed signiﬁcantly from control
animals, which were heat shocked but did not carry the rescuing
cDNA. To perform this latter analysis, we ﬁrst converted each of
the four time points in the experiment to a nominal ordinal value:
the time point before the heat shock is 1; the time point right after
the heat shock is 2; and so on. For each gene represented on the
array, we calculated the Pearson correlation coefﬁcient between its
expression level at each time point and the ordinal time value.
Permutation tests were used to evaluate the signiﬁcance of associ-
ation between the expression and the time of treatment. Genes in
this regression analysis that had negative slopes and differed sig-
niﬁcantly from control (P , 0.1), as well as the 1.8-fold decrease
from the preheat shock time point, were selected as reactivation
targets. Genes that did not fulﬁll either of these criteria were de-
ﬁned as our control, nondirect target set.
Statistical analysis
We performed logistic regressions to evaluate the relationship between
NMD targeting and several features by using the reactivation target set
and nonreactivation target set. Tested transcript features included
predictor variables: 39 UTR length; 39 UTR RNA structure, as evalu-
ated by CentroidFold RNA folding energy (Hamada et al. 2009); the
presence of introns in 39 UTR; potential stop-codon read-through
events, as deﬁned by (Jungreis et al. 2011); the length ratio between
39 UTR and the coding sequence; the presence of bi/poly-cistronic
transcripts; and the presence of stop codons in the 39 UTR. For
qualitative features, we set nominal values for the presence or absence
of the feature.
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Amplicon design and quantitative RT-PCR (qRT-PCR)
Primer3 (http://frodo.wi.mit.edu/) was used to design amplicons for
qRT-PCR experiments using a primer size of 23 bp, a melting tem-
perature of 62!, and designed to amplify a region of 602100 bps.
When possible, the amplicon, or the primers themselves, was designed
to span splice junctions to minimize the ampliﬁcation of contaminat-
ing genomic DNA. Primer pairs were tested for ampliﬁcation efﬁciency
with a wild-type cDNA dilution series. The following primers were
used: Gadd45 (1: qGadd45_F1 and qGadd45_R1; 2: qGadd45_F2
and qGadd45_R2); RP49: qRP49_F and qRP49_R; Copia; qCopia_F
and qCopia_R; and tra: qtra_F and qtra_R. All qRT-PCR analysis was
conducted using iQ SYBR Green master mix and a MyiQ thermal
cycler running iQ5 v2.0 software (Bio-Rad, Hercules, CA). RP49
(RpL32) served as a reference gene in all cases. Primer sequences listed
in Table S4.
S2 cell culture and RNA interference (RNAi)
We cultured Drosophila S2 cells at room temperature in Schneider’s
media (Invitrogen) supplemented with 10% fetal bovine serum and
antibiotics. To deplete cells of Upf1, we ampliﬁed a 771 base pair region
from the coding sequence of Upf1 using primers with T7 RNA poly-
merase sites at the 59 ends (Upf1_RNAi_F and Upf1_RNAi_R), and
used this product to synthesize double-stranded RNA (Megascript kit;
Ambion). We then incubated S2 cells with this dsRNA in serum-free
media for 45 min, replaced the serum, and allowed the cells to recover
for 3 d. We retreated with dsRNA to maintain the knockdown, allowed
a 3-d recovery, and then mock-treated or treated the cells with actino-
mycin D for 1 hr. RNA was collected and puriﬁed using Trizol reagent
(Invitrogen) and used to synthesize cDNA for qRT-PCR analysis.
RESULTS
Characterization of Upf225G mutant larvae
Previously, we have shown that hemizygous males harboring a strong
hypomorphic mutation in Upf2, called 25G, leads to stabilization of
NMD-sensitive reporter mRNAs, PTC bearing mutant transcripts,
and endogenous targets of NMD (Metzstein and Krasnow 2006).
However, we found that, unlike null alleles of Upf1 or Upf2, which
impart lethality in the second larval stage (L2), the development of
Upf225G/Y animals proceeds normally through these stages (Figure
1A). The start of the third larval stage (L3) also begins normally in
Upf225G/Y, but development then slows such that progression into the
pupal stage is delayed by approximately 24 hr (Figure 1B). Most
Upf225G/Y die as pupae, with only 14% of animals eclosing into adult-
hood (Figure 1A). Using the 25G hypomorphic mutation at the early
L3 stage thus allows us to examine the effects of NMD pathway
disruption without the complications of lethality and developmental
delay inherent to Upf2 null mutants.
Analysis of the transcriptome of Upf225G mutant larvae
To analyze the effect of NMD pathway disruption on endogenous
gene expression, we performed deep-sequencing on total RNA
extracted from Upf2+/Y and Upf225G/Y L3 larvae. Control and mutant
males were stage matched by rearing to 024 hr after the L2-L3 larval
molt, and total RNA was extracted and sequenced on the GAx II
Illumina platform (see Materials and Methods). Sequencing reads
were aligned to the reference genome (dm3) using Tophat software
under the pair-end mode (Trapnell et al. 2012). We analyzed two
biological replicates each of mutant and control samples and were
able to align 24253 million read pairs to the genome per sample
(Supporting Information, Table S1). Although we found reads repre-
senting expression of 14,699 genes, only 10,434 were detected in all
four samples and so this subset was used for subsequent statistical
analysis (File S1). Of these 10,434 genes, we identiﬁed 413 (4.0%) as
being differentially up-regulated at a signiﬁcance of P , 0.01 (Figure
1, C and D; top genes listed in Table S2 and all genes listed in File S2).
These genes were up-regulated between 1.8- and 330-fold in Upf225G
compared with control samples. A total of 247 genes were found to be
down-regulated in Upf225G/Y (Table S2 and File S2). We found that
genes encompassing a broad range of absolute expression levels are
subjected to NMD-mediated regulation (Figure 1D, Table S2, and File
S2).
Identiﬁcation of NMD reactivation targets
To identify which transcripts are directly targeted by the NMD
pathway, we used a pathway reactivation assay. Starting with an NMD
mutant, in which expression levels of both direct and indirect targets
should be elevated, a wild-type copy of the mutated factor is
expressed, and RNA expression levels are measured over time. It is
expected that expression levels of transcripts that are direct targets of
NMD should decrease rapidly. Conversely, the levels of indirect
targets will remain high until direct targets return to wild-type levels.
To perform this experiment, we used the bipartite UAS/GAL4 expres-
sion system (Brand and Perrimon 1993) to rapidly restore wild-type
Upf2 from a UAS:Upf2 transgene in Upf225G/Y mutant L3 larvae by
using the hsp70 enhancer to drive GAL4 in a heat-inducible manner
(Figure 2A). We conﬁrmed that the UAS:Upf2 transgene was func-
tional by testing for rescue; we found that UAS:Upf2 driven by Act5C:
GAL4 could rescue the null allele Upf214J to full viability in hemi-
zygous males (data not shown). In addition, we observed no lethality
or other defects from driving high-level expression of Upf2, either
constitutively, using Act5C:GAL4, or acutely after heat shock with
hsp70:GAL4, suggesting that these experimental conditions are un-
likely to result in ectopic degradation of non-NMD targets.
Our time course consisted of a preheat-shock time point, a t =
0 time point collected directly after a 30-min heat shock, and two
further time points, 2 and 4 hr after the completion of the heat shock.
As a control for the effect of the heat shock itself on gene expression,
we analyzed larvae that harbored Upf225G and heat-shock GAL4 but
not the UAS:Upf2 transgene. These larvae were treated to the same
heat-shock regime as the experimental samples. At each of the time
points, for both experimental and control samples, RNA was collected
and expression levels were measured using microarrays (see Materials
and Methods). Analysis of Upf2 expression levels revealed that Upf2
was activated over our time course approximately 12-fold in experi-
mental animals, but remained unchanged in control animals, as
expected (Figure S1).
We next developed a statistical model to test whether, for each
gene, reactivation of the NMD pathway led to a change in mRNA
abundance. Our primary assumption was that the expression levels of
mRNAs that are direct targets of the NMD pathway would decrease
rapidly during the course of the experiment. We deﬁned two
parameters to deﬁne whether a gene was a direct NMD target. First,
the expression level at the end of the 4-hr time course had to decrease
by 1.8-fold compared with preheat shock levels. Second, changes in
expression were compared with control samples (heat shocked, but
lacking the UAS:Upf2 transgene) to control for effects of heat shock
and culturing conditions, with a negative binomial model used to
compare differences in gene expression at each time point (see Mate-
rials and Methods). The difference in stability between experimental
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and control conditions is also described by a best-ﬁt linear regression
slope of the log-transformed expression level throughout the time
course, which assumes exponential decay of target genes. We refer
to this difference in stability as “relative slope” (Figure 2B).
After eliminating transcripts that displayed inconsistent expression
levels throughout the time course, such as those that were not
expressed at high enough levels for meaningful analysis (see Materials
and Methods for details), we were left with 6956 genes (File S3). We
found a small number of genes (154) that displayed the rapid decrease
in expression levels in experimental samples compared to controls
deﬁned above, and are thus putative direct targets of the NMD path-
way (File S4). We refer to these genes as reactivation targets. The other
6802 genes are deﬁned as nonreactivation targets and are not likely to
be directly regulated by the NMD pathway, although we cannot rule
out the possibility that some of these are indeed targets but their
expression does not change signiﬁcantly enough to be identiﬁed under
our experimental conditions.
Among the reactivation targets, we found well-known direct NMD
targets, including the NMD pathway components Smg5 and Smg6,
whose homologs are direct NMD targets in mammals (Huang et al.
2011; Yepiskoposyan et al. 2011), and have also been shown to be
direct targets in Drosophila cell culture (Rehwinkel et al. 2005). We
also found as a target Gadd45, homologs of which are known to be
direct NMD targets in mammals (Viegas et al. 2007; Huang et al.
2011; Tani et al. 2012a). To validate that other reactivation targets
represent direct substrates of the NMD pathway, we directly measured
transcript stability of several of them in Drosophila S2 cells with and
without a functional NMD pathway. Depletion of Upf1 by RNAi
resulted in stabilization of these mRNAs (Figure S2), indicating our
reactivation targets likely represent genuine direct targets of NMD. No
particular gene ontology category was enriched in the reactivation
data set, implying that NMD may regulate a functionally diverse array
of target genes.
Comparison of mutant expression changes and
reactivation targets
By combining the expression data from the RNA-seq experiment with
our reactivation experiment, we assigned genes to one of four classes
(Figure 2B). Some genes, such as Gadd45, are up-regulated in Upf225G
and were identiﬁed as reactivation targets. Others, such as GstD2, are
up-regulated in mutant animals but did not rapidly decay after reac-
tivation of Upf2. Conversely, some genes, such as Rip11, are not over-
expressed in Upf225G, but still had mRNA levels that decreased rapidly
upon Upf2 reactivation. Finally, most genes are neither up-regulated
in Upf225G nor change during the reactivation experiment. This latter
class includes genes such as Act5C that are known be unaffected by
NMD in numerous experiments.
To compare the sets of genes with expression changes in Upf225G
mutants with reactivation targets, we restricted our analysis to genes
that were both represented on our microarray, present in our deep
sequencing data set, and were well annotated in FlyBase (seeMaterials
and Methods). A total of 5539 genes fulﬁlled these criteria (File S5), of
which 149 are up-regulated in Upf225G and 125 are reactivation tar-
gets. Common to both the up-regulated and reactivation target sets
Figure 1 Phenotypic and transcriptome analysis of Upf225G. (A) Effective lethal phase of NMD mutants. Null mutations in Upf1 (26A; cyan) and
Upf2 (14J; orange) result in death during the second larval instar, as compared with control (green), the great majority of which survive to
adulthood. Animals hemizygous for a hypomorphic allele of Upf2 (25G; purple) die mostly as pupae, with approximately 14% escaping into
adulthood. (B) Upf225G /Y animals develop at a normal rate into L3 but are delayed in this stage of larval development. Solid lines represent the
proportion of animals in the L3 stage at each time point; dashed lines represent the proportion in pupal stages. The gray box indicates the
collection window (0- to 4–hr-old L3s) in which we compared gene expression changes between control and Upf225G/Y. (C) Proportion of genes
based on relative expression in Upf225G/Y compared with control, based on normalized RNA-seq read depth. (D) Scatter plot of all genes (gray
circles) with their average expression level on the x-axis and their relative expression change in Upf225G mutants on the y-axis. Signiﬁcantly up-
regulated and down-regulated genes (P , 0.01) are represented by green and red circles, respectively. In (A) and (B), error bars represent6 1 SD
(n . 118 for all genotypes).
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were 24 genes. Therefore, of the 149 up-regulated genes, we found
only 16% (24/149) are reactivation targets (Figure 3A and Table 1).
These data suggest that 84% of genes up-regulated in the Upf225G
mutant are indirect targets of the NMD pathway, likely responding
to expression changes of direct targets. However, that 16% of genes
up-regulated in NMD mutants are found to be reactivation targets
represents a signiﬁcant enrichment over the entire analyzed gene set,
in which only 2.3% (125 of 5539) of genes are reactivation targets
(Fisher exact test P-value = 5.85 · 10212). In addition, the relative
slope of the 149 up-regulated genes in Upf225G mutants is skewed
negatively, corresponding to degradation during NMD reactivation
(Figure 3B, gray bars), compared with the distribution across all
5,539 genes in the analysis (Figure 3B, black bars), also indicating that
up-regulated genes are enriched for direct targets.
Most remarkably, these data indicate that the majority (125 of 149)
of reactivation targets are not increased at steady state in Upf225G
(Figure 3A). Thus, even though these genes appear to be direct targets,
their steady expression levels are unaffected by loss of NMD pathway
function.
Structural features of genes regulated by the
NMD pathway
Several kinds of sequence and structural features are thought to
inﬂuence whether an mRNA is targeted by NMD (Schweingruber
et al. 2013). Current models of NMD, particularly in nonvertebrates,
suggest 39 UTR length is a primary signal that stimulates NMD tar-
geting (Kebaara and Atkin 2009; Kervestin and Jacobson 2012). Other
features that may direct transcripts for degradation include a weakly
structured 39 UTR (Eberle et al. 2008); a low ratio of coding sequence
to 39 UTR length (Brogna and Wen 2009); the presence of more than
one open reading frame in the transcript, including small upstream
open reading frames (He et al. 2003); the presence of introns in the 39
UTR (Le Hir et al. 2000); and the use of stop codon read-through as
a regulatory mechanism (Jungreis et al. 2011). Therefore, we asked
Figure 2 Identiﬁcation of direct targets of NMD using reactivation of Upf2. (A) Crosses used to generate larvae. Upf225G/FM7i ; UAS:Upf2 or
Upf225G/FM7i females were crossed to w/Y; hsp70:GAL4males. Upf225G/Y ; UAS:Upf2/ hsp70:GAL4 (experimental, blue) or Upf225G/Y ; +/ hsp70:
GAL4 (control, red) L3 male larvae were collected based on Act5C:GFP carried on the FM7i balancer (represented in green) and male gonadal
morphology. Larvae of the appropriate genotype were subjected to the heat-shock regime indicated on the right. (B) Examples of genes in the
four classes identiﬁed; Gadd45 (up-regulated in Upf225G/Y, reactivation target; upper left); Rip11 (not up-regulated in Upf225G/Y, reactivation
target; upper right); GstD2 (up-regulated, nonreactivation target; lower left); Actin5C (not up-regulated, nonreactivation target). Numbers in
parentheses represent the fold change observed in Upf225G/Y compared with control. X-axis represents the time points collected as in (A). Y-axis
is relative expression level (on a log2 scale) compared to the pre-heat shock time point (20.5 hr) within each genotype. We also deﬁne a relative
decay slope for each condition, calculated from the regression line of log-transformed data throughout the time course, equal to the slope of the
experimental condition (with cDNA) minus the slope of the control condition (without cDNA). Error bars represent 6 1 SD.
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whether any of these features are enriched in our NMD reactivation
targets compared with nontargets (Table 2). Most strikingly, we found
the median length of the 39 UTR in reactivation targets was 423 bases,
considerably longer than the 218 bases found in the nonreactivation
control set (P = 1.55 · 1025 from regression analysis) (Figure 3C). We
did not detect signiﬁcant enrichment for presence of introns in the 39
UTR, the ratio of length of the coding sequence to 39 UTR, predicted
free energy of the 39 UTR, read-through candidates, stop codon den-
sity in the 39 UTR, or polycistronic transcripts (Table 2). In contrast to
reactivation targets, the 149 mRNAs that show increased expression in
the Upf225G mutant have signiﬁcantly shorter 39 UTRs on average
than genes in our control set (median of 159 bases, P = 8.71 ·
1028; Table 2 and Figure 3C).
Comparison of in vivo NMD target analysis
to cell-culture analysis
Previously, the most expansive analysis of NMD targeting in Drosoph-
ila was performed in S2 cell culture (Rehwinkel et al. 2005). This
analysis identiﬁed a set of 184 “core” NMD targets, deﬁned as the
up-regulated genes after independent RNAi-mediated silencing of all
six known NMD factors in Drosophila. Of these 184 genes, 68 passed
our data quality control tests, thus allowing us to compare these genes
to our NMD-regulated candidates. We ﬁnd that these overlap between
the data sets is relatively small, with the majority genes up-regulated in
S2 cells not identiﬁed as up-regulated in our Upf225G mutant, or
identiﬁed as reactivation targets (Figure S3). This discordance between
our NMD targeting data collected in whole animals vs. data from cell
culture experiments is likely a reﬂection of the tissue, physiological,
and developmental stage differences between these two experimental
setups.
NMD does not directly regulate genomic load in vivo
A proposed role of the NMD pathway is to rid the cell of aberrant
transcripts, represented in part by transposable elements (TEs), and
sporadic transcripts containing nonsense mutations that arise from
errors in transcription or splicing (Mendell et al. 2004). A striking
ﬁnding of our RNA-seq analysis of Upf2 mutant larvae was a massive
increase in reads mapping to the endogenous TE Copia. In control
Upf2+ larvae, sequences derived from this LTR-family transposon
comprised 0.042% of all mappable reads. However, in Upf225G/Y,
Copia represented 0.77% of all reads (Table S1), a 17.4-fold increase.
To test whether Copia RNA is a direct target of NMD-mediated
degradation, we examined our reactivation samples. Because Copia
is not represented on the microarrays, we used for global reactivation
analysis, we used qRT-PCR to measure Copia mRNA in the reactiva-
tion time course (Figure 4). Copia undergoes an alternative splicing
event to generate two major mRNA species (Brierley and Flavell 1990)
and we used an qRT-PCR amplicon that detects both of these RNAs
(Figure 4A). We found that Copia did not behave like a direct NMD
pathway target in this assay, as Copia levels did not decrease sig-
niﬁcantly during our reactivation time course (Figure 4B). This
conclusion was corroborated from results obtained in S2 cells,
where RNAi-mediated depletion of Upf1 increased Copia expres-
sion levels but did not alter the decay rate of Copia RNA (Figure
4C). Thus, we conclude that Copia transcript levels are regulated
by processes downstream of direct NMD targeting, as we have
Figure 3 Analysis of reactivation targets. (A) Venn diagram showing overlap of genes that display increased expression in Upf225G/Y and
reactivation targets. (B) Distribution of relative change in slope (deﬁned in Figure 2) identiﬁed in reactivation experiment for all genes (black
bars) and genes up-regulated in Upf225G/Y (gray bars). (C) Cumulative percentage of 39 UTR lengths measured in nonreactivation targets genes
(5291 genes; blue), reactivation targets (168 genes; red), and genes up-regulated in Upf225G/Y (214 genes; green).
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found for the majority of genes that are expressed at increased
levels in NMD mutant backgrounds.
To test whether Upf225G/Y animals have an overall increase in
mRNAs that contain PTCs, we analyzed the proportion of reads in
our RNA-seq data that encode for nonsense transcripts (Table S3).
We found that such reads comprise 0.048% of all reads mapping to
mRNA in Upf225G, compared to 0.046% in controls. Thus, we found
no signiﬁcant difference in the proportion of nonsense reads between
Upf225G and control, suggesting that such mutant transcripts do not
accumulate in NMD mutants.
DISCUSSION
Although NMD has been established as an important pathway for
posttranscriptional gene regulation in eukaryotes, the identities of the
n Table 1 The 24 genes up-regulated in Upf225G and identiﬁed as reactivation targets, sorted by increased expression observed in
mutant
FBgn Gene Name Fold Up-Regulation in Upf225G P Value Relative Slope Relative Slope P-Value Fold Decay-4 hr
FBgn0040837 CG8620 11.84 2.38E-13 20.26 0.039 2.44
FBgn0034605 CG15661 8.84 1.39E-03 20.43 0.082 2.20
FBgn0033240 CG2906 7.30 1.95E-07 20.08 0.043 1.80
FBgn0029766 CG15784 6.52 1.29E-16 20.40 0.040 2.42
FBgn0261113 Xrp1 6.52 3.51E-17 20.39 0.041 1.94
FBgn0019890 Smg5 5.33 5.90E-05 20.54 0.044 2.44
FBgn0033153 Gadd45 5.00 2.23E-06 20.70 0.040 4.82
FBgn0039319 CG13659 4.85 1.84E-10 0.00 0.081 2.37
FBgn0037936 CG6908 4.50 1.18E-11 20.68 0.039 5.21
FBgn0034501 CG13868 4.33 9.15E-11 20.34 0.042 2.12
FBgn0014031 Spat 4.19 2.24E-10 20.15 0.087 2.68
FBgn0031643 CG3008 3.94 4.97E-09 20.14 0.043 1.85
FBgn0041627 Ku80 3.58 1.49E-05 20.26 0.040 1.85
FBgn0032981 CG3635 3.34 4.00E-03 20.19 0.077 2.06
FBgn0037391 CG2017 3.34 1.11E-04 20.20 0.034 2.32
FBgn0050424 CG30424 3.31 1.11E-03 20.46 0.082 2.34
FBgn0039328 CHKov2 3.14 3.11E-05 20.44 0.036 2.66
FBgn0039260 Smg6 2.88 3.13E-05 20.46 0.039 2.07
FBgn0035476 CG12766 2.70 1.47E-04 20.54 0.076 2.16
FBgn0042105 CG18748 2.60 3.14E-03 20.72 0.075 7.18
FBgn0086370 sra 2.59 8.02E-05 20.11 0.082 1.87
FBgn0037781 Fancl 2.51 1.58E-03 20.23 0.083 2.31
FBgn0085194 CG34165 2.13 3.54E-03 20.11 0.049 1.81
FBgn0039226 Ude 1.91 7.12E-03 20.50 0.088 2.20
Fold up-regulation and associated P value are obtained from RNA-seq data. “Relative slope” refers to the decay of transcript in Upf2-reactivated larvae calculated as
a linear regression of log2 transformed expression level relative to control larvae; see Figure 2. “Fold decay-4 hr” refers to the fold change in transcript level between
the preheat shock and 4-hr time point in animals carrying the Upf2 cDNA. FBgn, FlyBase gene number.









or Average P Value
d
Count
or Average P Value
Count
or Average P Value
Total 5289 215 n/a 154 n/a 24
39 UTR length, bases 450.2 275.4 8.7E-08 739.6 1.6E-05 261.4 2.8E-01
39 UTR structure, kcal/mol/base 20.024 20.023 0.1006 20.028 0.772 20.028 0.161
CDS/39 UTR length ratio 0.416 0.389 0.200 0.661 0.601 0.301 0.990
Read-through candidates 113 1 0.358 5 0.700 0 0.520
Bicistronic genes 23 2 6.5E-02 0 0.570 0 1.000
39 UTR intron present 256 8 0.761 14 4.7E-01 0 0.359
39 UTR stop codon density 0.067 0.070 0.052 0.066 0.976 0.066 0.859
Polycistronic genes 31 1 0.105 0 0.790 0 0.836
Up-regulated in Upf225G n/a n/a n/a 24 , 2e-16 n/a n/a
NMD, nonsense-mediated mRNA decay; UTR, untranslated region; CDS, coding DNA sequence; n/a, not applicable.
a
Genes that neither are up-regulated in Upf225G/Y mutants nor undergo increased decay upon Upf2 reactivation.
b
Count or average for the indicated feature.
c
Genes up-regulated in Upf225G/Y mutants.
d
P value based on logistic regression compared with nonresponding genes. Compared features are based on FlyBase annotations (R5.45); 39 UTR length is the
length of the longest annotated 39 UTR in nucleotides; read-through candidates as deﬁned in (Jungreis et al. 2011); free energy as calculated using CentroidFold
(Hamada et al. 2009)
e
Genes that undergo decay upon Upf2 reactivation.
f
Genes both up-regulated in Upf225G/Y mutants and that undergo decay upon Upf2 reactivation. Only genes that were detected in reactivation microarray
experiments are tabulated.
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directly regulated genes as well as the mechanism of targeting have
remained elusive. Identifying the direct targets has been particularly
challenging in intact, multicellular organisms. In this work, we have
used reactivation of the NMD pathway in an NMD-defective Dro-
sophila mutant to identify directly targeted genes. Transcripts that
rapidly decrease in abundance upon pathway reactivation are strong
candidates for direct targets of NMD-mediated degradation. We have
identiﬁed 168 candidate direct NMD targets, indicating that NMD
regulates a signiﬁcant proportion of the Drosophila genome. This
number may, however, be an underestimate due to intrinsic limita-
tions to our approach. For instance, we have examined NMD target-
ing at one speciﬁc stage of development, so we have not identiﬁed
NMD targeting of genes that are either not transcribed at this stage, or
transcribed but not translated, since NMD targeting is translation
dependent. Thus, this group of 168 genes likely represents a lower
limit to the number of genes directly targeted by the NMD pathway.
In addition to the reactivation assay, we have also measured the
change in steady-state expression level of all transcripts in NMD-
defective animals. A comparison of the reactivation and steady-state
analysis leads to two signiﬁcant conclusions. First, we found that only
16% of genes that are overexpressed at steady-state levels in the NMD
mutant behave like direct targets in our reactivation assay. This
ﬁnding suggests that, for most transcripts, the increased expression
observed in the NMD mutant is due to indirect effects caused by
NMD pathway disruption. Such a result was not unexpected, as it is
likely that changes in direct target expression will lead to changes in
downstream genes, either through speciﬁc regulation by overexpressed
direct targets, or through changes in organismal development or
physiology. In yeast, 45–54% of genes up-regulated in NMD mutants
are direct targets (Guan et al. 2006; Johansson et al. 2007). The ﬁnding
that in whole Drosophila, loss of NMD shows a greater percentage of
up-regulated indirect targets may be due to the diversity of tissue-
speciﬁc physiologic response brought about by loss of NMD
(Weischenfeldt et al. 2008; Bruno et al. 2011; Colak et al. 2013). This
scenario is important to consider when developing systemically ad-
ministered therapies designed to modulate NMD activity (Durand
et al. 2007).
Our second conclusion is more surprising. We found that 81% of
candidate direct targets do not show altered steady-state expression in
our NMD mutant. This implies there exist feedback mechanisms that
act to renormalize the expression of many NMD-target genes when
NMD function is compromised. Many gene expression networks
contain negative regulatory loops that act to restore expression to
physiological levels upon perturbation of pathway components
(Becskei and Serrano 2000). This feedback could function indirectly,
for instance at the transcriptional level, but in the case of NMD, the
feedback could also be working at the level of NMD pathway activity.
The NMD effectors Smg5 and Smg6 are direct NMD targets, both in
mammalian and ﬂy cells (Rehwinkel et al. 2005; Huang et al. 2011;
Yepiskoposyan et al. 2011), and our reactivation experiments demon-
strate direct targeting of these genes in intact Drosophila. The up-
regulation of Smg5 and/or Smg6 may compensate for the partial loss
of Upf2 function in our Upf2 hypomorph, restoring gene expression of
many direct targets to homeostatic levels. However, upon reactivation
of Upf2, these direct targets are poised for rapid degradation due to
increased expression of Smg5, Smg6, and other potential NMD factors.
Such a model may account for why in yeast a greater percentage of
direct NMD target genes show increased expression in NMD mutants
(Johansson et al. 2007), since there is no evidence for NMD pathway
autoregulation in this organism. That some directly targeted genes do
show up-regulation in Upf225G may be indicative of a greater depen-
dence of these genes on core NMD factors for their degradation, as
opposed to auxiliary regulators, as has been observed in a number of
studies (Chen et al. 2005; Metzstein and Krasnow 2006; Avery et al.
2011; Huang et al. 2011; Frizzell et al. 2012; Metze et al. 2013). A ﬁnal
speculative possibility is that NMD factors may also be required for
transcription of some direct NMD-mediated mRNA decay substrates,
as has been shown for yeast proteins involved in general 59-39 RNA
degradation (Haimovich et al. 2013; Sun et al. 2013). In this scenario,
loss of NMD factors results in reduced transcription of these NMD
targets, compensating for the concurrent increase in mRNA stability,
which results in unchanged steady-state expression levels. A number
of NMD factors are known to shuttle between the cytoplasm and the
nucleus (Isken and Maquat 2008), and some are known to have
nuclear functions (Brogna 1999; de Turris et al. 2011; Varsally and
Brogna 2012).
Although our conclusions that most genes up-regulated in NMD-
defective Drosophila are not direct targets of the NMD pathway, and
that many direct targets are not up-regulated, differs what has been
found in yeast (Guan et al. 2006; Johansson et al. 2007), they are
similar to ﬁndings in mammalian cell culture (Tani et al. 2012a). Tani
et al. (2012a) found that 23% of genes in HeLa cells that are up-
regulated under conditions of NMD deﬁciency appear to be direct
NMD targets, similar to the 16% we have shown here. They also
Figure 4 Copia RNA levels are indirectly regulated by
the NMD pathway. (A) Copia genomic (boxes) and
transcript structures. Also indicated is the quantitative
reverse-transcription polymerase chain reaction (qRT-
PCR) amplicon. (B) qRT-PCR analysis of Copia of the same
time course described in Figure 2. (C) Copia levels in S2
cells, measured by qRT-PCR, using the assay described
Figure S2 (fold change after Upf1 depletion indicated in
parentheses). Error bars represent 6 1 SD.
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observed that the great majority of genes (90%) that displayed NMD
pathway-dependent decay, and thus appeared to be direct degradation
targets, had no change in steady-state expression levels when the
NMD pathway was inactivated. Again, this is very similar to what
we have found in intact Drosophila, in which 81% of putative direct
targets have no signiﬁcant change in expression. That such similar
results were found using different methodologies in diverse organisms
suggests that the phenomenon of feedback regulation normalizing
levels of direct NMD targets is a general property of the NMD path-
way in metazoans.
Although a rapid decrease in mRNA expression levels upon Upf2
reactivation suggests that the gene is a direct NMD target, it remains
possible that the expression levels of some of our identiﬁed genes
decrease due to a non NMD mechanism. This alternative mechanism
is likely to depend on activation of a secondary RNA decay pathway,
as transcriptional changes in response to Upf2 expression is unlikely
in itself to lead to the rapid transcript decay we observe. Future
experiments, such as detection of speciﬁc NMD-dependent decay
intermediates, could be used to address this alternative possibility;
such an approach has been well established in cell culture, but not
previously in intact animals.
Most studies seeking to globally identify NMD targets have used
overexpression as the main criteria for being an NMD target (Lelivelt
and Culbertson 1999; He et al. 2003; Mendell et al. 2004; Rehwinkel
et al. 2005; Guan et al. 2006; Metzstein and Krasnow 2006; Wittmann
et al. 2006; Barberan-Soler et al. 2009; Ramani et al. 2009; McIlwain
et al. 2010; Nicholson et al. 2010; Yepiskoposyan et al. 2011; Hurt
et al. 2013; Matia-González et al. 2013). Cataloging NMD targets in
this way produces a list with a mix of indirect and direct NMD targets.
This in turn, convolutes the correlation between 39 UTR length and
the likelihood of being an in vivo NMD target, as has been observed in
previous analyses (Rehwinkel et al. 2005; Hansen et al. 2009; Ramani
et al. 2009; Yepiskoposyan et al. 2011; Rayson et al. 2012). In exper-
imental situations, long 39 UTRs generally make transcripts sensitive
to NMD (Kertész et al. 2006; Behm-Ansmant et al. 2007a; Longman
et al. 2007; Singh et al. 2008; Eberle et al. 2009; Hogg and Goff 2010).
Our examination of natural in vivo NMD targets supports this conclu-
sion: we ﬁnd that candidate direct NMD targets have considerably longer
39 UTRs on average than nondirect targets. Almost 50% of candidate
direct target transcripts have a 39 UTR over 420 bases in length, a value
suggested to be a threshold between NMD resistance and sensitivity
(Singh et al. 2008), compared with only 31% of nontargeted transcripts.
However, as has been found in mammalian cells, we ﬁnd that a large
number of transcripts that have long 39 UTRs are not subject to NMD
(with the caveat that, in most cases, deﬁning a transcript as NMD
sensitive in mammalian cells is based on increased expression when
the NMD pathway is disabled). Singh et al. (2008) have proposed such
long but NMD-insensitive transcripts contain speciﬁc NMD-protective
sequences. Conversely, we also ﬁnd that there are many genes with short
39 UTRs that appear to be direct NMD targets. Since most models
invoke a long 39 UTR as the trigger for NMD targeting, how structurally
normal, short 39 UTRs could be targeted is unclear. We propose these
transcripts may contain speciﬁc sequence features that stimulate NMD
targeting, analogous to yeast downstream elements (Peltz et al. 1993;
González et al. 2001). Although such elements are not required to
trigger decay in NMD-sensitive transcripts with long 39 UTRs, they
could be key to targeting mRNAs with short 39 UTRs. Furthermore,
the decay rates of both mutant PTC-containing and endogenous tran-
scripts are often quite variable when measured experimentally, a phenom-
enon that could be explained by the presence or absence of DSE-like
elements in these transcripts.
Finally, as described previously, our results regarding the number
of direct targets of the NMD pathway correlate well with the ﬁndings
in HeLa cells. However, the results from this study differed from ours
in one signiﬁcant aspect: in HeLa cells direct targets were found to
have shorter 39 UTR lengths than nontargets (Tani et al. 2012a),
a ﬁnding contradictory to our own and unexpected given current
models of NMD targeting. A possible explanation for this discrepancy
is that cell transformation is associated with a global alteration in
39 UTR length (Mayr and Bartel 2009). Potentially, the 39 UTR
lengths of NMD targeted transcripts in HeLa cells systematically differ
from the annotated human genome reference set, explaining the dis-
cordance. It will be important in the future to examine NMD targeting
in nontransformed mammalian cells to determine the contribution of
39 UTR length to NMD sensitivity.
One model for why the NMD pathway is required for viability is
that NMD functions to suppress transcriptome noise, such as the
noise arising from endogenous TEs or erroneously generated PTC-
bearing mRNAs. However, although we ﬁnd that the TE Copia is
highly up-regulated in Upf225G mutants, Copia RNA is not a direct
NMD target in vivo. Therefore, Copia up-regulation is likely due to
processes downstream of NMD, such as stress responses, which are
known to up-regulate Copia in other experimental situations (Strand
and McDonald 1985). Moreover, we ﬁnd no signiﬁcant enrichment in
reads that map to PTC-generating transcripts in Upf225G, suggesting
that NMD does not function to suppress such transcripts in vivo.
Since we ﬁnd no evidence that NMD suppresses genomic noise
in vivo, we favor a model in which NMD is required for viability
through regulation of particular critical NMD target genes. Therefore,
the understanding of the in vivo roles of the NMD pathway will re-
quire the identiﬁcation of these targets, particularly those that display
increased expression in NMD mutants, as it is likely that this in-
creased expression mediates the biological defects observed in
NMD-defective organisms and cells. Our analysis indicates that this
is a relatively short list; we ﬁnd only 24 genes appear to be both be
overexpressed and be direct targets at the developmental stage we
examined. The continued analysis of these 24 genes should reveal
important insights into NMD-dependent roles in normal develop-
ment and physiology.
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GADD45 IS A CRITICAL DIRECT TARGET OF THE NMD PATHWAY 
 
Abstract  
Although NMD is required for viability in most organisms, it is not known how it 
exerts its physiological roles. In this chapter, we exploit the results of an unbiased screen 
for effectors of the NMD loss-of-function phenotype to identify Gadd45 as a 
physiologically relevant NMD target. Gadd45 is upregulated in NMD mutants and is a 
direct NMD target in vivo. We have also generated the first mutants for Gadd45 in 
Drosophila and find that disruption of Gadd45 can ameliorate aspects of the NMD null 
mutant phenotype, such as developmental arrest. In conclusion, our results suggest that 
direct, negative regulation of Gadd45 by the NMD pathway is critical to organismal 
development and survival.  
 
Introduction 
In most organisms including Drosophila, zebrafish, mammals, and plants, NMD 
pathway genes are required for viability (Medghalchi et al., 2001; Metzstein and 
Krasnow, 2006; Weischenfeldt et al., 2008; Wittkopp et al., 2009; Yoine et al., 2006). 
While NMD genes are not necessary for viability in yeasts and C. elegans, they are 
required for the response to stress and for normal development of the reproductive organs, 
respectively (Cali et al., 1999; Hodgkin et al., 1989; Leeds et al., 1992; Matia-González 
et al., 2013). It is likely that function of the NMD pathway itself is required for 
development and physiology. For instance, within each organism, the loss of any 
individual NMD gene results in remarkably similar phenotypes, suggesting that it is 
NMD pathway function itself that has physiologically critical functions (Hwang and 
Maquat, 2011). In cases where different mutations produce a range of phenotypes, the 
severity of the NMD defect is typically correlated with the severity of other physiological 
and developmental defects (Frizzell et al., 2012; Metzstein and Krasnow, 2006). 
Additionally, NMD is required for wild-type regulation of gene expression due to the 
ability of the NMD pathway to directly destabilize endogenous target genes (Neu-Yilik et 
al., 2004). Taken together, these observations suggest that the NMD pathway is an 
important component of eukaryotic biology, and in NMD mutants, accumulation of 
native target genes interferes with normal development and physiology. 
While it is clear that NMD functions as a posttranscriptional regulator of 
physiologically relevant biological processes, in the vast majority of cases it is not known 
which NMD target genes are relevant to these processes (Johansson and Jacobson, 2010; 
Matia-González et al., 2013; Medghalchi et al., 2001; Metzstein and Krasnow, 2006; 
Weischenfeldt et al., 2008; Wittkopp et al., 2009; Yoine et al., 2006). Furthermore, there 
have been no unbiased screens designed to identify suppressors of NMD mutant 
phenotypes. Also, in most organisms, it is not known which of the genes upregulated in 
NMD mutants are direct targets and which are upregulated as a secondary consequences 
to misregulation of directly targeted transcripts. Distinguishing direct from indirect 
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targets is important to understanding the critical biological roles of NMD, as direct 
targets of NMD are presumed to control expression of secondary targets.  
In Drosophila, Upf1, Upf2  and Smg5 are required for viability, with mutant 
larvae dying in midlarval or pupal stages (Cali et al., 1999; Chapin et al., 2014; Hodgkin 
et al., 1989; Leeds et al., 1992; Matia-González et al., 2013; Metzstein and Krasnow, 
2006)(J.O. Nelson, unpublished data). NMD is also required for cell proliferation with 
NMD-mutant tissue being defective in cell/cell competition assays (Avery et al., 2011; 
Hwang and Maquat, 2011; Metzstein and Krasnow, 2006; Rehwinkel et al., 2005). 
Recently, we have identified a set of genes that are overexpressed in Drosophila NMD 
mutants and are direct targets of the NMD pathway based on a functional reactivation 
assay (Chapter 2 of this thesis and in Chapin et al., 2014). It is likely that one or more of 
these genes mediate the defects observed in NMD loss-of-function mutants.  
 Here, we present evidence that one of these 24 genes, Gadd45, is a critical 
downstream mediator of NMD mutant defects. We find that reducing the activity of 
Gadd45, or its critical downstream effector, Mekk1, can ameliorate the loss of NMD 
pathway activity, including developmental progression and cell proliferation. Our 
conclusions, supported by data presented in this study using Drosophila, may be 
applicable across taxa as Gadd45 homologues are also directly targeted by NMD in 





A deficiency rescue screen for genes that suppress the lethality  
associated with NMD dysfunction  
identifies Gadd45 and Mekk1 
Our approach took advantage of a screen previously conducted in the lab to 
identify genes with a functional, epistatic relationship to the NMD pathway (Materials 
and methods). This screen was based on the ability of heterozygous deficiencies to 
ameliorate the partial inviability of a strong Upf2 hypomorph, Upf225G. We tested a 
collection of 413 isogenic deficiencies for those that, when heterozygous, significantly 
increase the number of viable Upf225G/Y males above their 10% survival rate (Figure 3.1 
and Chapin et al., 2014). To quantify the ability of individual deficiencies to rescue 
Upf225G/Y, we developed a metric we call the “Deficiency Rescue Score” (DRS, see 
Materials and methods). Deficiencies with a DRS > 0 show suppression of Upf225G/Y, 
with scores > 0.1 considered significant. These deficiencies are thus candidates for 
containing critical NMD target genes (Figure 3.2).   
We first examined deficiency coverage of our 24 candidate target genes (Table 
3.1). Of these 24 genes, 9 were represented in our deficiency collection (14 total 
deficiencies). For three genes, Xrp1, CG18784, and Gadd45, all uncovering deficiencies 
had positive scores. However, for both Xrp1 and CG18784, at least one of these 
deficiencies had DRS scores below our cutoff, suggesting that the rescuing deficiencies 
that uncover Xrp1 or CG18784 may represent false positives. In contrast, Upf225G/Y is 
suppressed effectively by Df(2R)ED1673, a deficiency that uncovers the NMD target 
gene Gadd45. Two other deficiencies that do not rescue Upf225G/Y, Df(2R)ED1618 and 
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Df(2R)ED1715, flank Gadd45 but do not disrupt this locus, further supporting the notion 
that Gadd45 is the critical target gene uncovered by Df(2R)ED1673 (Figure 3.3A). This 
screen also identified two overlapping deficiencies, Df(3R)ED2 and Df(3R)ED5911, that 
uncover Mekk1 (Figure 3.3B). Interestingly, the deficiencies that uncover Mekk1 can also 
rescue a cell proliferation defect observed in NMD mutants (Figure 3.4 and Materials and 
Methods).  
 
Gadd45 disruption can ameliorate NMD  
loss of function defects 
To test the hypothesis that Gadd45 is the rescuing gene uncovered by 
Df(2R)ED1673, we generated mutant alleles of Gadd45 using TALEN-mediated 
mutagenesis (Figure 3.5 and Materials and Methods). This procedure generated a mutant 
allele with a disruption to the Gadd45 coding sequence, Gadd4554C. This allele eliminates 
six in-frame amino acids, does not disrupt the reading frame, and therefore is not 
predicted to be a null allele. As a control, we also isolated a chromosome that had gone 
through the TALEN procedure but has no detectable change in Gadd45, Gadd4541B.  To 
test if Gadd45 mediates the NMD-mutant phenotype, we asked if Gadd4554C behaves 
similarly to Df(2R)ED1673, which partially rescues Upf225G/Y as a heterozygote. We 
found that Gadd4554C partially rescued viability in Upf225G/Y , while Gadd4541B did not 
(Figure 3.6A). However, rescue by Gadd4554C is to a lesser degree than Df(2R)ED1673, 
suggesting that Gadd4554C is a hypomorphic allele (as predicted from sequence analysis), 
or that other important loci exist within the rescuing deficiency.             
We next asked if Gadd45 disruption can rescue the predominantly L2 lethal phase 
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of NMD null mutant animals (Chapin et al., 2014). We analyzed the lethal phase of 
Upf214J mutants that were also homozygous for either Gadd4541B or Gadd4554C. This 
analysis revealed that ~80% of Upf214J; Gadd4541B larvae arrest and die in the L2 stage, 
with the remainder dying in L1; a similar lethal phase to which we observed for this allele 
of Upf2 (Chapin et al., 2014)(Figure 3.6B). This lethal phase is in contrast to Upf214J/Y; 
Gadd4554C, which die predominantly as L3 (Figure 3.6B). The partial rescue of the 
NMD-mutant lethal phase from L2 to L3 by the disruption of Gadd45 indicates that 
Gadd45 overexpression in an NMD mutant inhibits development past the L2 stage.  
 
Loss of Mekk1 suppresses NMD-mediated defects 
To identify the role of Mekk1 in the NMD mutant phenotype, we tested a loss of 
function allele known as Ur36 (Inoue et al., 2001). This allele was generated using 
imprecise excision techniques and removes 868 bp coding for the kinase domain and is 
thought to be a null. We crossed animals harboring Mekk1Ur36 to Upf225G/FM7i animals 
and assayed for viability of F1 Upf225G/Y; Mekk1Ur36/+ animals. We found that Mekk1Ur36 
partially rescues viability, similar to that of the rescuing deficiency that uncovers the 
Mekk1 locus (Figure 3.7), and suggests that Mekk1 is the rescuing gene uncovered by 
Df(3R)ED2 and Df(3R)ED5911. As Mekk1 is known to be an important downstream 
effector of Gadd45, our result that Mekk1 also appears to mediate the NMD loss-of-
function phenotype and strongly implicates the Gadd45/Mekk1 signaling pathway as a 
critical target pathway of NMD.     
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A large portion of the genes regulated by Mekk1 are  
secondary targets of the NMD pathway 
Mekk1 is transcriptionally activated in response to epithelial wounding, and the 
expression of several genes involved in the wounding response are upregulated in a 
Mekk1 dependent manner (Brun et al., 2006). We asked if the transcriptional output of 
Mekk1 activation resembled gene expression changes brought about by a loss of NMD 
function. To test this hypothesis, we compared the list of Mekk1-dependent wounding 
genes to those upregulated in Upf225G/Y animals (Brun et al., 2006; Chapin et al., 
2014)(Table 3.2). Of the 13 genes upregulated in a Mekk1-dependent manner upon 
wounding, six are upregulated in > 1.5 fold in Upf225G/Y mutants. Also, none of these six 
genes are reactivation targets, suggesting that NMD indirectly negatively regulates a 
large proportion of genes that are also activated by Mekk1.  
 
The 3’ UTR of Gadd45 is targeted by  
NMD in intact larvae 
To test the hypothesis that it is the long 3’ UTR of Gadd45 that renders the 
transcript sensitive to NMD, we constructed a UAS/eGFP reporter using the Gadd45 3’ 
UTR. We then asked if this construct is susceptible to NMD-mediated decay (Figure 
3.8A). When we used e22c:GAL4 to drive expression of the transgene in both wild-type 
and Upf225G mutant backgrounds, we found GFP expression was much higher in 
Upf225G/Y animals compared to Upf2+/Y (Figure 3.8B). It is known that NMD does not 
affect GAL4 transcription (Metzstein and Krasnow, 2006), thus the changes in GFP 
expression we observe are most likely due to differences in transcript stability. This result 
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suggests that the Gadd45 3’ UTR is sufficient to induce NMD.   
 
Discussion 
The identification of the critical target genes of NMD (i.e., native genes which 
require regulated degradation by the NMD pathway to allow for normal development) is 
important to understanding the overall function of the NMD pathway in vivo. While 
many NMD targets have been identified, none have previously been shown to be 
causative of the NMD mutant phenotype. Indeed, until our work, no assay had yet been 
performed to distinguish direct from indirect NMD targeting genome-wide in an intact, 
multicellular organism (Chapin et al., 2014). Additionally, no functional screens have 
been performed to identify relevant NMD target genes. Using two approaches, one based 
on the identification of direct targets in vivo and one based on the suppression of NMD 
mutant phenotypes, we have identified Gadd45 as a candidate direct target that functions 
in mediating aspects of the NMD mutant phenotype.   
Interestingly, there is evidence that regulation of Gadd45 transcript levels by the 
NMD pathway is evolutionally conserved. GADD45β (also called MyD118), one of three 
Gadd45 homologues found in mammals (Takekawa and Saito, 1998), has been shown to 
be a direct NMD target, possibly via an intron present in its 3’ UTR (Viegas et al., 2007). 
Drosophila Gadd45 does not contain an intron in its 3’ UTR and indeed splicing, unlike 
in mammals, is not thought to be crucial for NMD targeting in insects. However, the 3’ 
UTR of Drosophila Gadd45 is relatively long (743 bases compared to the genome-wide 
median of 460 bases) a length we have shown is sufficient to render a reporter construct 
sensitive to NMD. Long 3’ UTRs in Drosophila and other organisms are a predisposing 
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feature that increases the likelihood of targeting by NMD (Behm-Ansmant et al., 2007).   
As NMD negatively regulates Gadd45, it is predicted that any gain-of-function, or 
activation, phenotype of Gadd45 will resemble the NMD loss-of-function phenotype. 
Phenotypes associated with activation of GADD45-family proteins and the observed 
defects of NMD mutants suggest that Gadd45 may be an important target of NMD. 
GADD (Growth arrest and DNA damage) family genes were identified in mammalian 
cell culture as mRNAs that are activated following treatment with DNA damaging agents, 
such as UV light, that lead to cellular growth arrest (Fornace et al., 1988; Papathanasiou 
et al., 1991). Activation of Gadd45β, one of three Gadd45-family mRNAs appears to be 
physiologically relevant as overexpression of Gadd45 in mammalian cell culture is 
sufficient to induce cell cycle arrest (Jin et al., 2002; Takekawa and Saito, 1998) and in 
certain circumstances, apoptosis (Mak and Kültz, 2004). These phenotypes mirror those 
of NMD inhibition in mammals, where silencing of Upf1 in cell culture induces cell cycle 
arrest (Azzalin and Lingner, 2006), and complete loss of Upf1 function in mouse cells 
induces apoptosis (McIlwain et al., 2010; Medghalchi et al., 2001).  
The parallel phenotypes between Gadd45 activation and NMD loss of function 
are also recapitulated in Drosophila. siRNA-mediated inhibition of the six major trans-
acting NMD factors in Drosophila S2 cell culture results in cell cycle inhibition 
(Rehwinkel et al., 2005). Moreover, null mutants for Upf1, Upf2, and Smg5 are all 
inviable (Metzstein and Krasnow, 2006; J.O. Nelson and M. M. Metzstein, in prep), and 
global overexpression of Gadd45 leads to inviability (Peretz et al., 2007). Additionally, 
mosaic analysis has revealed that cells deficient for Upf1 or Upf2 in the egg chamber 
(Avery et al., 2011) or the eye (Metzstein and Krasnow, 2006) arrest growth in an 
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apoptosis-dependent manner (Avery et al., 2011), reminiscent of Gadd45 overexpression 
in the egg chamber, which induces apoptosis (Peretz et al., 2007). Another striking 
phenotypic similarity manifests in eggshell patterning, where germline clones mutant for 
Upf1 or Upf2 result in fused eggshell dorsal appendages (Avery et al., 2011), a defect that 
can also be induced through overexpression of Gadd45 in the germline (Peretz et al., 
2007). The phenotypic similarities between NMD disruption and Gadd45 overexpression 
are suggestive of an epistatic relationship and support our model that Gadd45 could 
mediate a significant portion of the loss-of-function NMD phenotype.  
Our conclusion that NMD mutants are physiologically affected by Gadd45 
upregulation is supported by our finding that disruption of Mekk1 can also suppress the 
loss-of-function NMD phenotype. MTK1, as Mekk1 is known in mammals, encodes a 
MAPKKK and is an obligate downstream signaling effector of Gadd45. MTK1 has been 
shown to be activated by GADD45 through direct protein/protein interactions, resulting 
in phosphorylation (Mita et al., 2002; Miyake et al., 2007; Takekawa and Saito, 1998). 
This phosphorylation activates MTK1, allowing it to act as an upstream regulator of 
MAPK signaling (Chen et al., 2002; Inoue et al., 2001), which in many contexts results in 
induction of apoptosis (Kang et al., 2012), similar to NMD loss of function mutations and 
Gadd45 overexpression.      
Several other lines of evidence suggest a functional relationship between NMD, 
Gadd45, Mekk1, and MAPK signaling. While the direct activation of MEKK1 by 
GADD45 has not been tested in Drosophila, evidence suggests that activation of MAPK 
signaling could mediate the Gadd45 overexpression phenotype. Disruption of 
hemipterous (hep), a signaling kinase protein upstream of jun N-terminal kinase (JNK) 
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and downstream of MEKK1, can rescue the fused dorsal appendage phenotype induced 
by Gadd45 overexpression (Peretz et al., 2007). Furthermore, in Drosophila S2 cell 
culture, hep is required downstream of Mekk1 in the MAPK stress response pathway that 
is activated by cadmium and arsenite (Ryabinina et al., 2006). 
 Gadd45/MAPK signaling has also been studied in Drosophila in relation to stress 
responses that result from septic injury (De Gregorio, 2002; De Gregorio et al., 2001) and 
sterile wounding (Stramer et al., 2008) during which Gadd45 is acutely upregulated. 
Other genes that are indicative of active JNK signaling, such as genes of the humoral 
immune system, are also upregulated during wounding. JNK pathway activation is 
functionally required for an effective response to wounding as JNK pathway mutants are 
cell-autonomously defective in wound healing (Galko and Krasnow, 2004; Rämet et al., 
2002). The upstream kinases that initiate JNK signaling in wounding responses are not 
known; however, it is known that MEKK1 is activated during the wound response (Brun 
et al., 2006). For instance, the Turandot genes, which are involved in the humoral 
immune response (Ekengren and Hultmark, 2001), are strongly activated by wounding 
itself, and this response is blunted in animals mutant for Mekk1 (Brun et al., 2006). We 
observed that many of these Mekk1 dependent genes are also upregulated in Upf225G/Y 
but are not reactivation targets (and thus upregulated indirectly), suggesting that Mekk1 
signaling is activated in NMD mutants. 
Our data support a model where NMD is required to negatively regulate Gadd45 
throughout development (Figure 3.9). In NMD mutants, Gadd45 transcript is stabilized, 
presumably resulting in increased level of GADD45 polypeptide and subsequent 
activation of MEKK1. Active MEKK1 in turn activates MAPK signaling pathways, such 
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as JNK and p38, resulting in transcriptional activation of downstream stress genes. We 
predict that when NMD mutant tissue succumbs to apoptosis, as occurs in the egg 
chamber (Avery et al., 2011), that this is initiated through stabilization of Gadd45. As 
precocious activation of Gadd45 in the egg chamber during oogenesis causes widespread 
apoptosis and oocyte inviability (Peretz et al., 2007), it suggests that negative regulation 
of Gadd45 by the NMD pathway begins at a very early time point in development. In 
support of this hypothesis, the creation of NMD mutant germline clones also results in 
apoptosis and oocyte inviability (Avery et al., 2011). To test the hypothesis that Gadd45 
stabilization results in apoptosis in NMD deficient germline tissue, germline clones could 
be generated that are double mutant for NMD genes and Gadd45, with the prediction that 
double mutant clonal tissue is resistant to apoptosis induced by loss of NMD pathway 
activity.        
Our observations represent one example out of a very small number of instances 
where a loss of NMD function phenotype can be attributed to overexpression of a direct 
target. In S. pombe, double mutants between NMD genes and rex2 (a direct target) can 
rescue the sensitivity to oxidative stress observed in NMD single mutants (Matia-
González et al., 2013). In Arabidopsis, NMD activates an immune-like response (Rayson 
et al., 2012), and NMD defects can be ameliorated by introducing mutations that block 
full immune function (Riehs-Kearnan et al., 2012), suggesting that Arabidopsis NMD 
mutants succumb to autoimmune-like processes. As MAPK signaling is widely 
implicated as a positive activator of the Drosophila immune response, a very similar 
scenario may be at play in Drosophila NMD mutants.   
The observation that Gadd4554C does not rescue NMD null mutants into 
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adulthood could suggest that there are additional targets of NMD and further suggests 
that NMD is required at multiple time points in development. For instance, Gadd45 could 
be required after the L2/L3 molt, but this requirement is occluded due to Gadd45-
independent lethality that arises before adulthood. However, our Gadd45 allele is a mild 
disruption and could be indicative that this allele is hypomorphic in nature. Thus, full 
disruption of Gadd45 function could result in a more complete rescue of animals 
harboring NMD null alleles. Therefore, it remains a possibility that Gadd45 could solely 
be responsible for the NMD loss-of-function phenotype.    
Our conclusions that Gadd45 is directly and critically targeted by NMD raises 
questions about the role of the NMD-mediated type of regulation in development and 
physiology, specifically how NMD-mediated regulation may confer an evolutionary 
advantage. One possibility is related to the role of NMD in the silencing of viral 
transcripts. As NMD can efficiently target viral transcripts, many viruses have evolved 
countermeasures to evade such targeting. For example, the Rous sarcoma virus encodes 
cis-acting sequence features, known as RSV stability elements, that render its transcripts 
insensitive to NMD (Withers and Beemon, 2010). Additionally, the human T-
lymphotropic virus type 1 (HTLV-1) expresses the protein Tax, which inhibits NMD in 
trans (Mocquet et al., 2012). These two observations imply that viruses are forced to 
overcome NMD surveillance to replicate in host cells. Moreover, cytomegalovirus vMIA 
protein has been shown to inhibit Gadd45 (Smith and Mocarski, 2005). Taken together, 
these observations imply that NMD/Gadd45 can act as a functional viral response 
pathway. One model concerning the role of negative regulation of Gadd45 by NMD is 
that this system may have evolved to act as an early warning system to viral infection. If 
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a virus such as HTLV-1 enters a cell and inhibits NMD in trans, native target genes such 




 In this chapter, a deficiency rescue screen is described that identified a potentially 
important NMD target gene, Gadd45. To directly test the role of this gene in the NMD 
pathway, TALEN technology was used to create the first partial loss-of-function alleles 
of Gadd45. These alleles partially rescue the L2 lethal phase of Upf1 and Upf2 null 
mutants. To our knowledge, this is the first time a functional, direct target of the NMD 
pathway has been identified. We also tested another gene identified in the screen, Mekk1, 
which is an obligate downstream effector of Gadd45 activity, and showed that disruption 
of this gene also rescues the NMD loss-of-function phenotype. These results strongly 
suggest that Gadd45/Mekk1 signaling is overactive in NMD mutants and contributes to 
inviability. The incomplete nature of the rescue phenotypes suggests that Gadd4554C is 
either a hypomorph and/or that other important direct NMD target genes exist and that 
NMD has many different roles that are necessary for viability and relies on different 
direct target genes to execute its function. It is likely that these other critical target genes 




Materials and methods 
Stocks and reagents 
 Upf126A, Upf113D, Upf225G, and Upf214J are described in Metzstein and Krasnow 
(2006). For all experiments, these alleles are balanced over FM7i-Act:GFP for 
identification of hemizygous males in larval stages. Lethal phases were conducted using 
Upf214J/FM7i; Gadd4541B and Upf214J/FM7i; Gadd4554C females crossed to FM7i/Y; 
Gadd4541B and FM7i/Y; Gadd4554C males. For the GMR:hid analysis (Stowers and 
Schwarz, 1999), stocks of the following genotype were generated: pGMR-hid, y1, w* 
FRT19A/FM7c; ey-FLP. These animals were crossed through stocks carrying the indicated 
deficiency before mated as males to stocks harboring NMD alleles. Final genotypes were 
FRT19A w* NMD- /pGMR-hid, y1, w* FRT19A ; ey-FLP/+; Df/+. All genotypes were 
tracked using visual markers. For imaging, the eyes of anesthetized flies were imaged in 
several focal planes using a compound microscope and individual images compressed to 
a single, in-focus image using the stack focuser plugin for ImageJ 
(http://imagej.nih.gov/ij/). Next, ImageJ was used to calculate the area of each eye by 
manually defining the boarder of total ommatidia.           
 
Cloning of the eGFR:Gadd45 3’ UTR 
To clone the 3’ UTR of Gadd45, a 1050 bp fragment was PCR amplified from 
genomic DNA using Phusion polymerase and the following primers: G45_3U_X1_F and 
G45_3U_S1_R (Table 3.3). The template DNA used was from a stock that had been 
recently isogenized for the 2nd chromosome and harboring FRTG13, the same stock used to 
induce Gadd45 mutations. The fragment contained the 746 bp annotated 3’ UTR of 
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Gadd45 plus 304 bases to ensure any cryptic polyadenylation signals were also included. 
This fragment was then TOPO-Blunt cloned into pCR4 and sequenced, revealing several 
SNPs when compared to the reference sequence published on FlyBase. This fragment 
was digested out of pCR4 using the XbaI and StuI sites included in the forward and 
reverse primers, respectively, and ligated into the “K1” vector (pUASTw/Attb-GFP) 
digested with Xba1 and Stu1. This procedure replaces the SV40 3’ UTR with the newly 
cloned Gadd45 3’ UTR. The final vector contains UAS:eGFP-Gadd45 3’ UTR along 
with a backbone-localized Attb site for ΦC31-mediated transformation. The construct 
was injected into flies harboring the VK27 Attp docking site on the 3rd chromosome by 
Genetics Services, Inc. Three lines were established and shown to be functional by 
confirming GFP expression after crossing to actP:GAL4 (not shown). 
 
High-resolution melt analysis (HRMA) 
 Four primer pairs (all combinations of forward and reverse primers of: 
Gadd45_F3, Gadd45_F4, Gadd45_R7 and Gadd45_R8) were tested at three temperatures 
(68 °C, 70 °C, 72 °C) for optimal amplification of gDNA isolated from FRTG13/+ animals. 
This led to the selection of Gad45_F3 and Gadd45_R7 (120 bp amplicon) at 70 °C for 
use in all downstream HRMA analysis. All G0 and F1 flies subjected to HRMA were 
homogenized in squishing buffer and 1ul of gDNA used in the PCR reaction. Following 
amplification, a HB96 light scanner (Idaho Technologies, UT)  was used for the HRMA 
that would detect heteroduplex DNA and thus potential mosaic or heterozygous 
aberrations in the tested amplicon. Information about founding G0 mutants is listed in 
Table 3.4. 
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Deficiency rescue screen 
To mitigate the effects of background mutation, we selected a collection of stocks, 
referred to as the “DrosDel” collection, that carry custom, molecularly defined 
deficiencies that were generated in an isogenic w1118 background (Ryder et al., 2007). For 
our screen, we used 412 stocks from the DrosDel collection with deficiencies located on 
the 2nd, 3rd, and 4th chromosomes. Upf2 is located on the X, and therefore our screen was 
not easily adaptable to studying any effect of deficiencies located on this chromosome. In 
total, this collection covered 67.4% of all bases (disrupting 63.7% of all loci) on the 
chromosomes tested (Table 3.5). To conduct the screen, males from each of the 412 
stocks were individually crossed to Upf225G/FM7i virgin females (Figure 3.1). Male F1 
progeny from this cross were collected over a period of several days and scored for 
genotypes using visible markers. X chromosome genotypes could be distinguished by 
presence or absence of the Bar gene on FM7i balancing Upf225G. Chromosomes 
harboring the deficiencies could be distinguished by absence of the balancers in the Df 
stock (usually CyO for the 2nd and TM6C, Sb for the 3rd) or w+ linked to the deficiency 
itself (Ryder et al., 2007).       
 To assess the impact of the various deficiencies on Upf225G/Y viability, we 
measured the proportion of Upf225G/Y to FM7i/Y between animals that harbored 
deficiencies and those that did not. To control for breeding conditions and the impact of 
the deficiency on overall (non-NMD dependent) viability, we compared the proportion of 
Upf225G/Y males both carrying the deficiency and carrying the corresponding balancer 
within the same cross. The difference in the portion of Upf225G/Y larvae that are balancer 
positive from the portion that are deficiencies positive gives a so-called Deficiency 
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Rescue Score (DRS) (Figure 3.1). A DRS of 0 indicates that the deficiency has a neural 
effect on Upf225G/Y viability. Thus, a DRS of < 0 indicates the deficiency had a negative 
impact on viability, whereas a DRS > 0 indicates the deficiency has a rescuing effect. The 
majority of deficiencies tested  (90.6%) had no significant effect on or were detrimental 
to Upf225G/Y viability. 
 
To generate mutant alleles of Gadd45 
We used a TALEN-based approach that has been demonstrated to work in 
Drosophila (Liu et al., 2012) coupled to high resolution melt analysis (HRMA) for 
mutation detection. Gadd45 is located on the right arm of the second chromosome, and 
we chose to induce mutations in a lab strain that carries FRTG13, located at the base of 2R. 
This background was selected for a number of reasons: First, inducing mutations on the 
FRT-bearing chromosome would streamline subsequent experiments, such as mosaic 
analysis by eliminating the need to recombine the mutant alleles and the FRT. Second, 
FRTG13 is marked with w+, making for a convenient linked marker with which to follow 
the mutant chromosome. Third, the FRTG13 chromosome in this stock had recently been 
isogenized procedure, assuring that recovered alleles should be in a similar genetic 
background.  
Prior to TALEN design, Sanger sequencing was used to confirm that the locus 
encoding Gadd45 in the FRTG13 stock matched the reference genome (data not shown). 
Next, TALEN monomers were designed to bind on either side of a spacer sequence 
between the 36th and 50th nucleotides of the predicted Gadd45 CDS. In vitro transcribed 
mRNA coding for each TALEN was injected into G0 embryos at either 200 or 400 pg/µl 
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and the embryos allowed to develop into adulthood (Table 3.4). Surviving G0 adults 
(males and females) were mated with a w- lab strain for several days before being isolated 
and homogenized to extract gDNA for HRMA analysis. In total, 21 fertile G0s were 
screened from a total of 44 that survived the injection. w+ F1 progeny from the 14 G0s 
that were identified as containing heteroduplex DNA (and therefore possible mutations in 
Gadd45) were selected for propagation. 5 through 30 F1 progeny from each candidate G0 
were outcrossed to a CyO balancer stock and allowed to mate for several days before 
being removed and subjected to a similar HRMA procedure as the G0s. This identified 
five candidate F1s lines carrying mutations in Gadd45. These five lines were propagated 
by sibling-pair matings between w+; Cy F2s to create balanced lines. In all cases, Cy+ 
progeny were observed in the F3 generation, indicating these putative mutations were not 
homozygous lethal.        
 Upon sequencing of homozygous F3s, 4 deletions were identified from 2 
founding G0 lines (Table 3.4). One of the original five lines, named 41B, was revealed to 
be a false positive from the HRMA and had no changes from the original FRTG13 line. 
Three of the alleles, 41D, 54C, and 54M, are in-frame deletions of 18 bp, whereas 41E 
eliminates 21 bp, and as such, none of these alleles are predicted to disrupt the Gadd45 
reading frame (Figure 3.5B). Very little is known about the structure/function of 
GADD45, it is therefore challenging to predict how these alleles will behave in 
comparison to wild-type. The amino acids deleted in these alleles are in an unconserved 
region of the protein compared to the three mammalian homologues (Figure 3.5C). We 
used Gadd4554C as a representative mutant allele and Gadd4541B as a control.     
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EVIDENCE OF SPECIFC SPATIAL AND TEMPORAL  
FUNCTIONS OF THE NMD PATHWAY  
 
Introduction 
 The developmental requirement for NMD components indicates that this pathway 
has functions beyond the targeting and decay of nonsense alleles. The “Swiss Army 
Knife” model of NMD function states that NMD directly regulates a handful of critical 
target genes in a way that is essential for viability (Neu-Yilik et al., 2004). This model is 
in opposition to the “vacuum cleaner” model, which states the critical function of NMD 
is related to its role as a surveillance pathway degrading nonfunctional RNAs. One 
prediction of the Swiss Army Knife model is that NMD may have tissue-specific 
functions as expression patterns of critically regulated native target genes could be tissue-
specific. Similarly, this model also states that NMD could have temporal-specific critical 
functions. For example, NMD may critically target a specific transcript in particular 
tissue and/or at a particular time in development in a way that is sufficient for organismal 
viability. Therefore, if tissues can be identified where NMD is either sufficient or 
necessary for viability, it would suggest not only that essential and specific target genes 
exist, but also indicate in what tissues such critical targets are expressed. Furthermore, by 
experimentally controlling when NMD is active over the course of development, we can 
identify any temporal specificity of NMD function that may exist.  
To test for critical spatiotemporal roles of NMD, we conducted a tissue-specific 
rescue screen for tissues where NMD function is sufficient for viability. This screen 
revealed that function of NMD neuronal tissue is sufficient to rescue the L2/L3 molting 
defect of Upf2 null mutants. Additionally, by employing a genetic-based method to 
control when NMD components are active over the course of development, we find that 
function of zygotic NMD components during embryogenesis and midlarval stages may 
be sufficient to rescue NMD null mutants into adulthood. Taken together, these results 
support the Swiss Army Knife model, suggesting that NMD has specific, critical 
functions in neuronal tissue early in development and that NMD may be dispensable for 
viability in all adult tissues.           
 
Results 
Tissue-specific rescue screen 
In this screen, a library of spatially restricted GAL4 drivers were used to restore 
NMD function in an NMD-defective genetic background. Upf214J was used as 
representative NMD-defective background and therefore UAS:Upf2WT was used to rescue 
function. 80% of Upf214J/Y larvae die as second instar larvae (Chapin et al., 2014), and 
we defined “rescue” as development to wandering third larval instar (WL3). The GAL4 
driver library consisted of a collection of 30 stocks available from the Bloomington Stock 
Center that we characterized as having a restricted expression pattern along with three 
ubiquitous expressing drivers (Materials and Methods; Table 4.1). FM7i-act:GFP/Y; 
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GAL4/+ animals were crossed to Upf214J/FM7i; UAS:Upf2WT (Figure 4.1A). By 
examining GFP expression provided by the FM7i-act:GFP, mutant (GFP negative) and 
nonmutant (GFP positive) WL3 progeny could be scored in the F2. 1/4 of total progeny 
in this cross are Upf214J/Y; GAL4/UAS:Upf2 or Upf214J/Y; +/UAS:Upf2. As larvae of the 
latter genotype die in the second larval stage (L2), the presence of GFP-negative WL3 at 
a frequency of 1/7 total progeny indicates 100% rescue.      
To assess the rate at which escaper Upf214J/Y; +/UAS:Upf2 larvae develop into 
WL3, we first examined the calculated degree of rescue when no GAL4 is present. This 
proved to be very minimal under the breeding conditions used; 3% of expected (Figure 
1B). Next, we confirmed that the UAS:Upf2WT transgene can rescue to WL3 when it is 
globally expressed using an Act5C:GAL4 driver. We observed that this GAL4 expression 
rescues to 138% of expected for full rescue (Figure 4.1B). That fact this rescue is greater 
than 100% is not unexpected as animals carrying the FM7i balancer are slightly 
developmentally delayed compared to nonbalancer, wild-type animals (data not shown), 
implying that our rescued Upf214J mutants are actually more fit that balancer-carrying 
larvae. Similar results were obtained when using other ubiquitous drivers (Figure 4.1B). 
Most GAL4 drivers did not exhibit any capacity to rescue. However, a handful of 
drivers with restricted expression patterns rescue to varying degrees (Figure 4.1B). For 
instance, P{GawB}48Y was able to rescue to 113% of predicted. This driver expresses in 
the central nervous system (CNS) and imaginal discs, in addition to various cells in the 
trachea, midgut, and hindgut. P{GAL4-Hsp70.PB}31-1 rescues to a lesser degree (64%) 
but also has a more restricted pattern, limited to the CNS, midgut, and hindgut. Lastly, 
P{GawB}60IIA rescues to 50% and is limited in expression to neuronal tissue and weak 
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expression in the epidermis and imaginal discs. We also observed partial rescue with 
P{GawB}inscMz1407 (39%) and P{GAL4-elav.L}2 (43%), both of which have expression in 
the CNS. One unifying feature of the expression patterns of these five GAL4 drives is 
expression in the CNS. In particular, P{GawB}60IIA is quite restricted to and strongly 
expressed in neuronal tissue (Figure 4.2). These data suggest that NMD activity in the 
CNS is sufficient for development into the WL3 stage. 
 
NMD activity during late embryogenesis and larval stages may be  
sufficient for adult viability. 
 To test the hypothesis that the critical activities of NMD occur at limited time 
points in development, we borrowed logic from classical experiments that define critical 
periods of gene function through characterization of the “temperature-sensitive period” of 
temperature-sensitive alleles (Tarasoff and Suzuki, 1970). These classic experiments rely 
on activating and deactivating gene function by using temperature sensitive alleles. As no 
such alleles of NMD components are available in fly, we used Act5C:GAL4 combined 
with a temperature-sensitive GAL80 to control expression of a rescuing UAS:Upf2 cDNA 
in Upf214J males (Figure 4.3A). As this GAL80 unfolds and loses activity at 29 °C, this 
temperature is permissive for NMD function by allowing for GAL4-mediated expression 
of the rescuing UAS:Upf2. At the restrictive temperature of 18° C, GAL80 folds 
appropriately, thus inhibiting expression of UAS:Upf2.  
We first ensured that expression of UAS:Upf2 could be modulated using 
temperature in a way that is physiologically relevant. To do this, we measured the 
proportion of Upf214J/Y males to total male progeny that developed when held 
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constitutively at the permissive temperature (29 °C) or the restrictive temperature (18 °C). 
This analysis revealed that Upf214J/Y adult males developed to 53% of expected at 29 °C 
(Figure 4.3B). In separate experiments where no GAL80 is present, UAS:Upf2 driven by 
actin GAL4 rescues Upf214J/Y to 100% of expected (data not shown), indicating that the 
GAL80ts used in the constitutively permissive experiment may have some residual 
activity at 29 °C. When Upf214J/Y; Act5C:GAL4/+, tubP:GAL80ts/+ larvae are held at the 
restrictive temperature, no adults enclosed, indicating that GAL80 was able to inhibit 
expression of the UAS:Upf2 cDNA to levels incompatible with viability (Figure 4.3B). 
Note that this experimental approach cannot be used to inhibit activity of maternally 
deposited, wild-type Upf2 gene product. Thus, this experiment can only assay the zygotic 
requirements for Upf2.  
 To test for the end point of any NMD critical period, we tested for the latest time 
point larvae could be shifted from the permissive to restrictive temperate and still allow 
for development into adulthood at rates equal to that of constrictive NMD function at the 
permissive temperature. Multiple parental broods (Materials and Methods) were bred in 
vials at 29 °C, and F1 progeny allowed to develop at this temperature before being 
downshifted to 18 °C at various times points 0−6 days after egg lay. Adult F1s were 
collected, and the portion of Upf214J/Y males out of total progeny was calculated for each 
time point representing days before the downshift (Figure 4.3C, red line). From this 
analysis, we find that NMD activity can be inactivated as early as 2 days after egg lay and 
still allow for a small portion of Upf214J/Y to development into adulthood. When NMD is 
inactivated at 4 days after egg lay, a portion of Upf214J/Y males eclose which is similar to 
that of our control experiment where animals are kept at the permissive temperature 
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throughout development. These results suggest that zygotic Upf2 is only required at early 
time points in development, as opposed to being strictly required for steady state 
physiology and that this critical window ends sometime in late embryogenesis/early 
larval stages.  
To identify the beginning of this critical window of NMD function, larvae were 
bred at the restrictive temperature and upshifted to the permissive temperature at time 
points identical to those in the downshift experiment. We find that even very early 
activation of Upf2 does not lead to full viability of Upf214J/Y, suggesting that zygotic 
Upf2 is required at these early time points (Figure 4.3C, blue line). Taken together, our 
upshift and downshift data suggest that the critical period of zygotic NMD function is 
from less than 6 hours after egg lay to less than 4 days after egg lay, roughly 
corresponding to embryogenesis and midlarval stages.  
 
Functional assessment of RNAi-mediated silencing  
of NMD components 
 In the future, a tissue-specific RNAi screen could be used to assess the necessity 
of NMD components in various tissue types. A screen such as this would likely utilize the 
same library of GAL4 drivers in combination with UAS constructs that induce inhibition 
of NMD pathway components. As a proof of principle experiment, we tested several UAS 
transgenes designed to induce RNA-mediated silencing of NMD components, or 
expression of a dominant negative form of Upf1 (UPF1-DN), for their ability to inhibit 
NMD. RNAi transgenes for all NMD components were publically available, except Upf1, 
for which we generated using two constructs targeting separate regions of Upf1 (see 
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Materials and Methods).  
 To test the impact of these NMD-inhibiting transgenes on NMD function, all 
RNAi/DN stocks were crossed to a reporter stock that carried btl:GAL4 and an NMD-
sensitive UAS:eGFP-SV40 3’ UTR reporter (Metzstein and Krasnow, 2006). Tracheal 
GFP expression in the third larval stage was compared between F1 progeny both with and 
without the RNAi or DN constructs. In all cases, targeting of any NMD factor with any of 
the RNAi/DN transgenes produced an upregulation in eGFP signal (Figure 4.4). As NMD 
has been shown to have no effect on transcription of GAL4 (Metzstein and Krasnow, 
2006), our data indicate that all these NMD-inhibiting transgenes have a stabilizing effect 
on the eGFP RNA, indicating NMD function as at least partially compromised.           
 
Discussion and future directions 
Function of the NMD pathway is predicted to have critical roles in development 
and physiology. However, especially in higher eukaryotes, these roles are very poorly 
understood, and it remains unknown how the NMD pathway might fit into regulation of 
these processes. At the molecular level, NMD has been shown to function as a 
surveillance pathway and to be involved in the regulation of specific target genes, but it is 
not known which types of target are regulated most critically. The data presented in this 
chapter support the Swiss Army Knife model of NMD function, such that, at least in 
Drosophila, NMD critically regulates specific target genes. First, as NMD is thought to 
function in most tissue types (Avery et al., 2011; Metzstein and Krasnow, 2006; 
Rehwinkel et al., 2005), our results that an NMD null mutant can be partially rescued in a 
tissue-specific manner imply that the physiologically relevant targets of NMD are also 
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tissue-specific. Furthermore, our experiments to identify critical time periods of NMD 
function suggest that function in early embryogenesis or early larval stages is sufficient 
for viability into adulthood. As aberrant or “junk” transcripts are thought to be produced 
at all times in all tissues throughout development, our observation that NMD pathway 
function is not required in the adult suggests that the surveillance capabilities of NMD are 
not necessary for viability.  
Taken together, our data support a model where NMD function in the central 
nervous system (CNS) during embryogenesis and early larval stages is sufficient for 
viability into adulthood. This model is consistent with evidence from Drosophila and 
mammalian studies that NMD functions in important postmitotic and development 
processes in neuronal tissue, such as in long-term potentiation at synapses (Giorgi et al., 
2007), proper synaptic vesicle cycling and morphology of the neuromuscular junction 
(Long et al., 2010), axon guidance (Colak et al., 2013), and proper brain development 
and/or function in human (Tarpey et al., 2007). Also in agreement with our model are 
observations in mice that NMD activity is gradually downregulated in neuronal tissue 
over the course of development and that this downregulation is actually required for 
neurodevelopment (Bruno et al., 2011). If NMD is regulated in a similar way in 
Drosophila, it would agree with our data suggesting NMD activity is not required in 
adults. Moreover, this model predicts that overactivation of NMD in Drosophila would 
inhibit neurodevelopment, or perhaps produce other gain-of-function NMD phenotypes. 
If overactivation of NMD does have detrimental effects in Drosophila, it could explain 
observations from our lab that overexpression of Upf1, even when using tissue-restricted 
GAL4 drivers, often leads to lethality. However, it is not known if overexpression of 
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Upf1 in fact leads to hyper activation of the NMD pathway.  
One possible mechanism by which NMD activity in the CNS controls the L2/L3 
molt is through regulation of the mechanisms that result in production of 20-
hydroxyecdysone (20E), a steroid hormone that controls molting and pupariation (Edgar, 
2006; Metzstein and Krasnow, 2006). Under wild-type, nutrient-rich conditions, 
ecdysone (a precursor to 20E) is produced and released by the prothoracic gland in 
response to stimulation by prothoracicotropic hormone (PTTH). PTTH is synthesized and 
released in a highly regulated fashion by a pair of neurosecretory cells in the CNS that 
innervate the prothoracic gland (McBrayer et al., 2007). Given our rescue data, it could 
be possible that the NMD is required in some process that stimulates PTTH release and 
by extension, the initiation of molting/pupariation. This model could be tested by asking 
if ptth:GAL4 (McBrayer et al., 2007), which expresses only in the PTTH-producing cells, 
can rescue the L2/L3 the molting defect in Upf214J.      
In one model, NMD mutants upregulate putative negative regulators of PTTH 
release, and restoration of NMD in neuronal tissue alone renormalizes these negative 
regulators to wild-type levels, allowing for normal PTTH release and thus rescue of the 
L2/L3 molt. However, this model is based on necessity of NMD pathway activity in the 
CNS, which our tissue-specific rescue screen did not directly test. To examine the 
necessity of NMD in CNS, it will be important to test whether tissue-specific inhibition 
of NMD in the CNS is incompatible with developmental progression. Such an 
experiment could be executed using RNAi transgenic reagents combined with our 
rescuing GAL4 drivers, provided that it can be demonstrated that these RNAi/DN 
transgenes can induce physiologically relevant silencing of NMD components. Several 
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attempts were made to use these RNA/DN constructs to study neuron-specific aspects of 
the NMD loss of function phenotype. However, these results were inconclusive for many 
reasons. First, many transgenes designed to silence NMD components previously 
characterized as vital did not induce lethality when expressed globally using Act5C:GAL4. 
In the future, techniques aimed at enhancing the ability of RNAi transgenes to induce 
silencing, such as co-expression with siRNA pathway component DICER, or incubating 
animals at higher temperatures, could be used to augment the silencing ability of the 
available RNAi lines. In pilot studies, the presence or absence of visible markers was 
used to assess whether the transgenic combinations were lethal, and any RNAi or GAL4 
transgenes that were mapped incorrectly would cause this approach to fail. Thus, these 
transgenic stocks should be rebalanced to ensure that all visible markers correspond to 
the appropriate genotype.   
A second, different interpretation of our CNS rescue data is that NMD function in 
the CNS is sufficient, but not necessary for developmental progression. The interruption 
of the L2/L3 molt that occurs in Upf214J could be caused by defects that arise in 
nonneuronal tissues, yet activation or overexpression of Upf2 in the CNS bypasses these 
nonneuronal defects and initiates the L2/L3 molt regardless. Interestingly, this model fits 
with the current understanding of PTTH-mediated stimulation of ecdysone release. It has 
been observed that ablation of the PTTH producing cells does not lead to full inhibition 
of molting or pupariation, suggesting that functional ecdysone release can be stimulated 
through other channels (McBrayer et al., 2007). If it is found that NMD function in the 
CNS is not necessary for viability, one interpretation would be that although PTTH 
release is defective in animals with CNS-specific silencing of NMD components, NMD 
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activity in nonneuronal tissue is sufficient to induce ecdysone release. When NMD 
mutant animals are rescued with expression in CNS, while lack of NMD activity in 
nonneuronal tissues is not sufficient to drive molting, expression in the CNS is sufficient 
for PTTH release.   
This proposed mechanism would also fit with our data showing that Upf126A and 
Upf214J mutants developmentally arrest for weeks before they die as second or third instar 
larvae (data not shown). These data suggest that loss of NMD pathway function is not 
acutely lethal to larvae, but rather inconsistent with developmental progression. If this 
arrest is related to insufficient ecdysone production, it would be possible under this 
proposed mechanism that the induction of pathways leading to ecdysone release would 
rescue the molting defects of Upf1 and Upf2 null mutants. A test of this model would be 
to treat NMD mutants with purified 20E and ask whether this is also sufficient to bypass 
the second instar arrest.    
Our interpretation that NMD function in the CNS is sufficient to rescue the L2/L3 
molting defect in NMD mutants does have caveats. In the future, it will be important to 
ensure that NMD function has been restored only to the tissues were we believe the 
GAL4 to be expressed. Such an experiment could be conducted using expression of 
NMD-sensitive reporters in NMD-rescued larvae. Expression patterns of these GAL4s 
are not well characterized beyond our own work observing expression of fluorescent 
reporters (Table 4.1) and could have functional expression in other tissues that we can not 
observe using such reporters. Other important controls for this sufficiency experiment 
would include using a separate UAS:Upf2 cDNA to control for positional effects of 
individual transgenes. It would also be important to demonstrate rescue of other null 
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alleles of Upf2 and perhaps Upf1 (which also arrest at the L2/L3 molt), although this 
latter experiment might be impossible as overexpression of Upf1 in a number of specific 
tissue types results in organismal lethality.      
While fitting with certain data, our conclusion that the critical period of NMD 
function ends in larval stages could be at odds with other observations concerning NMD 
function in the fly. For instance, as has been shown in cell culture (Rehwinkel et al., 
2005) and whole Drosophila (Avery et al., 2011; Metzstein and Krasnow, 2006), NMD 
function is required for cell proliferation. As cell proliferation is required in pupal stages, 
it is interesting that we identified the end of the critical period as between 3 and 4 days, a 
time point corresponding to early L3 and over 24 hours before pupariation. Additionally, 
Smg5 null mutants die during pupariation (J.O. Nelson and M. M. Metzstein, in prep), 
which also suggest that NMD has critical functions at this stage. This disparity could be 
explained in two ways. First, our temperature sensitive period experiments are designed 
to identify critical periods of gene function, not to identify when mutant defects manifest. 
Therefore, it is possible that some aspect of NMD function during early developmental 
time points is important for the cell proliferation that occurs during pupal stages. Another 
explanation for this disparity is related to the limitations of our experimental design. It is 
possible that, while the shift to 18 °C does inhibit GAL80, the perdurance of the RNA or 
protein corresponding to the Upf2 cDNA lasts into pupal stages, thus rescuing any critical 
NMD-mediated functions at these later time points. If this perdurance is long enough, it 
could also explain why we observe any adult Upf214J/Y males at all in the downshift 
experiment to the restrictive temperature.  
The issue of perdurance is a vitally important caveat to the interpretation of these 
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data. When this experiment is repeated in the future, measurements should be made of 
Upf2 mRNA and protein levels throughout the downshift time course. Additionally, 
NMD function itself, as measured through upregulation of direct NMD target transcripts, 
should also be assayed at various time points to ensure that NMD is in fact inhibited in a 
timely manner following the shift to the restrictive temperature. If it cannot be 
demonstrated that NMD is sufficiently inhibited in pupae and adults following downshift 
in larvae, it will invalidate our conclusions about this critical period of NMD function.          
 
Materials and methods 
Stocks and reagents 
Upf126A and Upf214J are as described in Metzstein and Krasnow (2006). For the 
“temperature sensitive period” experiments, the GAL80ts is P{w[+mC]=tubP-
GAL80[ts]}10 (from Bloomington Stock Number 1708) recombined with Act5C: GAL4. 
The UAS:Upf2 is as described in Chapin et al., (2006). The GAL4 reporter line harbors 
UAS:GFP and UAS:nlsDsRed reporters. A complete list of the lines in the tissue-
restricted GAL4 library is available in Table 4.1.  
 
Cloning of Upf1 RNAi transgene 
 To clone RNAi constructs directed against Upf1, two target sequences were 
cloned, an “A” and a “B” of 437 and 422 base pairs, respectively. Each target sequence 
was amplified from gDNA two times, once using primer pairs that create a 5’ NotI site 
and a 3’ XhoI site (“left”) and again using primer pairs that create a 5’ XbaI site and a 3’ 
KpnI site (“right”). Primers sequences are available in Table 4.2. All 4 fragments were 
104
first TOPO-TA cloned into PCR4 (Invitrogen, CA) and then sequentially ligated into 
pUAST-I w/Attb starting with the “left” fragments for both the “A” and “B” versions. 
This vector is designed to position the “left” version of the target sequence upstream of 
the “right” version, such that the “right” and “left” are co-expressed as a sense and 
antisense version, creating double stranded RNA and thus inducing RNAi directing 
towards the target sequence. Following completion of the cloning, both plasmids were 
sequenced and shown to contain no changes from the published sequence. These 
constructs were injected into flies harboring the VK26 (3rd chromosome) or Attp16 (2nd 
chromosome) AttP sites for ΦC31-mediated integration. Transgenic stocks were isolated 
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CONCLUSIONS AND FUTURE DIRECTIONS 
 
The nonsense mediated mRNA decay (NMD) pathway is a conserved, eukaryotic 
cellular surveillance pathway originally identified for its role in the rapid turnover of 
transcripts harboring nonsense mutations (Belasco, 1993). Subsequent investigation has 
revealed that NMD can also target and degrade other kinds of aberrant RNAs, in addition 
to wild-type, error-free messages (He et al., 1993). Additionally, function of the NMD 
pathway is essential for numerous biological processes across eukaryota and is required 
for overall viability in more complex organisms (Hwang and Maquat, 2011). Taken 
together, these observations evoke a model wherein NMD mediates essential functions 
through destabilization of native substrate RNAs. However, this model has not been 
completely tested and many questions surrounding the function of NMD remain 
unanswered. As described in this thesis, we have used the model genetic organism 
Drosophila melanogaster to address such questions as: What portion of the transcriptome 
is subject to NMD-mediated regulation? What cis-acting features sensitize transcripts to 
NMD-mediated decay? What kinds of RNAs are most critically targeted; 
nonfunctional/aberrant transcripts, or functional/error-free RNAs? Are there specific 
target genes that are critically regulated by NMD? 
Chapter 2 describes experiments designed to identify target transcripts of NMD in 
intact animals. Previous research has often defined NMD target genes as those transcripts 
that are upregulated in backgrounds where NMD has been disabled. In Drosophila L3 
larvae, we find that a significant portion of the transcriptome (4%) is upregulated in our 
representative NMD mutant, Upf225G. This result is in agreement with previous reports in 
Drosophila S2 cell culture, as well as in other model organisms, which indicate similar 
levels of upregulation when Upf2 is inhibited (Rehwinkel et al., 2005; Weischenfeldt et 
al., 2012). Also like other organisms, we observe that many ontological categories are 
represented in our list of upregulated genes, implying that NMD regulates a range of 
biological processes. One overrepresented category is composed of genes involved in the 
defense response, suggesting that NMD functions to suppress the response to pathogens. 
This observation mirrors what has been described in Arabidopsis, where NMD mutants 
display an upregulation of pathogen response genes. This upregulation appears to be 
physiologically relevant, as Arabidopsis NMD mutants are resistant to pathogen infection 
(Riehs-Kearnan et al., 2012). Moreover, mutations that block full upregulation of defense 
response genes rescue other aspects of the NMD loss-of-function phenotype, including 
subviability.  
While analysis of steady-state expression levels in NMD mutants is useful in 
understanding the overall role of NMD, these techniques cannot distinguish between 
primary and secondary effects of the mutation; i.e., between direct and indirect target 
mRNAs. With this consideration, we adapted a reactivation assay (Johansson et al., 2007; 
Maderazo et al., 2003), used previously only in yeast, to parse our list of NMD targets 
into direct (reactivation targets) and indirect (nonreactivation targets). Our finding that a 
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minority (16%) of genes upregulated in Upf225G appear to be direct targets mirrors 
observations in HeLa cells, where only 23% of genes which are upregulated following 
silencing of Upf1 display a longer rate of decay compared to controls (Tani et al., 2012). 
This result implies that the majority of changes in gene expression following inhibition of 
NMD in human cells are indirect. That this study came to a similar conclusion about the 
portion of directly targeted transcripts found upregulated in NMD-mutant backgrounds 
(and by using a very different experimental approach) supports the notion that in complex 
organisms, NMD exerts the majority of influence over steady-state gene expression by 
indirect means. In yeast, a greater proportion of genes upregulated in Upf2Δ strains are 
reactivation targets (54%), suggesting that the majority of gene expression changes in this 
organism that occur in mutant backgrounds are direct effects of stabilization (Belasco, 
1993; Johansson et al., 2007). In agreement with this conclusion is the observation that 
only a few genes are downregulated by inhibition of NMD in yeast, also implying that 
there exist far fewer indirect targets in this organism (He et al., 1993, 2003). This 
observation is in contrast to Drosophila and human cells, in which many genes are 
downregulated in NMD mutants (Hwang and Maquat, 2011; Rehwinkel et al., 2005; Tani 
et al., 2012). Thus, while dissimilar to yeast, our estimate about the proportion of primary 
and secondary targets is similar to findings in HeLa cells, suggesting the overall 
regulatory role of NMD on the Drosophila transcriptome may be more similar to the role 
of NMD in mammals.    
Because the reactivation assay is not based on any other criteria, including steady-
state levels in a mutant background, we also identified another class of genes in addition 
to direct and indirect NMD targets. This third class of genes are those identified as 
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reactivation targets, but are not upregulated in Upf225G. We refer to these “renormalized 
targets,” as it is presumed that these genes are directly targeted, but also subject to 
compensatory downregulation such that the steady-state levels are not divergent from 
wild-type. Of our reactivation targets, only 19% are upregulated in Upf225G/Y, indicating 
that 81% are renormalized. This class of target gene is rarely discussed in the NMD 
literature, but has been observed in yeast, where 32% of reactivation targets are not 
upregulated in NMD mutants (Johansson et al., 2007; Rehwinkel et al., 2005; 
Weischenfeldt et al., 2012). Recent observations in HeLa cells indicate that only 10% of 
transcripts that are stabilized by silencing of Upf1 are also upregulated (Riehs-Kearnan et 
al., 2012; Tani et al., 2012). This latter observation again mirrors our results in 
Drosophila and bolsters the notion that the majority of directly targeted transcripts are in 
fact renormalized such that no expression level change is detected at steady-state.            
 That we find so many renormalized target genes could be explained by a few 
scenarios. One possibility is that renormalized target genes are positively 
transcriptionally regulated by processes mediated by NMD itself or individual NMD 
factors. For instance, NMD genes could act as transcriptional co-activators that are 
necessary for the expression of renormalized target genes. Thus, in NMD mutants, while 
renormalized target mRNAs are more stable, their rate of transcription is also decreased, 
which results in minimal deviation in expression level from wild-type. While speculative, 
this scenario has been proposed when considering other RNA decay processes. For 
example, the 5’ to 3’ exonuclease Xrn1 has been shown to promote the transcription of 
many of its decay target. In Xrn1 mutants, while the large majority of genes are stabilized, 
there is little overall change in global transcript levels (Haimovich et al., 2013; Johansson 
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et al., 2007; Maderazo et al., 2003). Supporting the possibility that NMD components 
could act in a similar way, NMD factors have been shown to have nuclear functions. For 
instance, UPF1 has been show to shuttle between the nuclease and cytoplasm (Tani et al., 
2012; Varsally and Brogna, 2012), and deletion of Upf1 has been shown to effect 
transcriptional kinetics of NMD decay targets (de Turris et al., 2011).       
Our overall conclusions that a minority of genes upregulated in Upf225G/Y are 
direct targets and that the expression levels of a minority of direct targets are changed in 
Upf225G/Y mutant could have broad implications in the study of the cis-acting sequence 
features that sensitize transcripts to NMD. In many studies, features such as a long 3’ 
UTR are enriched, but imperfectly correlated with NMD target status (Behm-Ansmant et 
al., 2007; Eberle et al., 2009; Hansen et al., 2009; Kebaara and Atkin, 2009; Rayson et al., 
2012; Singh et al., 2008; Yepiskoposyan et al., 2011). Many of these studies rely on 
upregulation in an NMD mutant background to define NMD targets. This definition of an 
NMD target, in light of our observations, which suggest that only a minority of 
upregulated genes are directly targeted, could explain the weak associations with putative 
targeting features and actual targeting status. For instance, we show that a long 3’ UTR is 
not associated with genes upregulated in Upf225G/Y, but is associated with genes defined 
as reactivation targets. These data not only bolster our conclusion that the reactivation 
assay has identified bona fide direct targets of NMD, but also may help explain the weak 
associations with 3’ UTR length in other studies that use upregulation to define NMD 
targets. However, we still observe that many of our reactivation targets do not have long 
3’ UTRs, suggesting that other sensitizing, cis-acting features of native NMD substrates 
remain undiscovered. In the future, it would be interesting to examine more properties of 
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our reactivation targets. For instance, our deep sequencing data could be used to examine 
if reactivation targets are enriched in genes that are inefficiently spliced, as such genes 
have been shown to be directly targeted by NMD. This hypothesis could be tested by 
quantifying reads mapping to pre-RNAs versus RNAs and comparing this measurement 
between wild-type and Upf225G/Y.  
In Chapter 3 of this dissertation, we more closely examine the 24 genes that are 
both upregulated in Upf225G/Y and were identified as reactivation targets. We refer to this 
group as “critical target genes” because one or more of these genes are likely to mediate 
the NMD loss-of-function phenotype in Drosophila. To help narrow our focus to only the 
most important of these 24 genes, we first cross-referenced our list of critical targets with 
the results of a deficiency rescue screen conducted previously in the Metzstein lab. This 
screen was designed to identify physiologically relevant target transcripts. From this 
screen, a small number of genomic regions were identified that are predicted to contain 
important mediators of the NMD loss of function phenotype. One of these regions 
contains the critical target gene Gadd45, which we confirm is a direct NMD target in 
intact larvae by demonstrating that its long 3’ UTR is sufficient to render a reporter RNA 
NMD-sensitive. We then show that disruption of the Gadd45 CDS can partially rescue 
the subviability of Upf225G/Y mutants and the L2-arrest associated with Upf214J/Y mutants. 
These results establish that upregulation of Gadd45 interferes with normal development 
and mediates at least part of the NMD mutant phenotype. These results establish Gadd45 
as a physiologically relevant critical target gene. To our knowledge, this is the first such 
gene identified in metazoa.      
In support of our conclusion that Gadd45 is a physiologically relevant NMD 
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target gene, we also show that disruption of Gadd45’s obligate downstream signaling 
partner, Mekk1, can also rescue Upf225G/Y subviability. Moreover, we also observe that 
six of the 13 known transcriptional targets of Mekk1 are found as indirect targets of NMD. 
Taken together, these observations fit into a model wherein NMD functions to negatively 
regulate levels of Gadd45, such that in strong NMD mutants, the stabilization of Gadd45 
leads to inviability through the activation of MEKK1.  
Data from other labs indicate that the negative regulation of Gadd45 by the NMD 
pathway is evolutionarily conserved and that this regulation could have physiologically 
relevant consequences in other lineages. For instance, Gadd45β, a mammalian 
homologue of Drosophila Gadd45, is a direct target of NMD, possibly via its 3’ UTR-
localized intron (Viegas et al., 2007). Similar to Drosophila, this targeting could also 
have relevant functions in mammals as phenotypes associated with Gadd45 activation in 
both these model systems mirror those of NMD loss of function. For instance Gadd45 
activation has been shown to promote cell cycle arrest and apoptosis (Jin et al., 2002; 
Mak and Kültz, 2004; Peretz et al., 2007; Takekawa and Saito, 1998), two process that 
are also stimulated by NMD inhibition in both systems (Avery et al., 2011; Azzalin et al., 
2007; McIlwain et al., 2010; Medghalchi et al., 2001; Rehwinkel et al., 2006). A 
particularly striking example of these similarities is observed in Drosophila, where both 
Gadd45 overexpression and NMD loss of function specifically in the female somatic 
germline both result in the same eggshell pattering defect, fusion of the dorsal 
appendages (Avery et al., 2011; Peretz et al., 2007).  
While our data do support the model that Gadd45 is a true physiologically 
relevant critical target of NMD, our conclusions are limited because our data, including 
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sequence analysis of Gadd4554C, indicate that this allele is likely hypomorphic. In the 
future, alternative strategies, or a new round of TALEN mutagenesis, must be used to 
obtain null alleles of Gadd45. One approach would be to repeat the same TALEN 
strategy, but use a different set of HRMA primers that may be able to detect larger and/or 
different mutations. Three other primer pairs have been tested that generate amplicons of 
slightly different size around the predicted TALEN cut site, and all three amplicons 
appear to be amenable to the HRMA procedure. One possible reason that we did not 
obtain null alleles using the allele recovery strategy outlined in Chapter 3 is that Gadd45 
null mutants may be lethal. This situation would create a bias when selecting injected G0 
animals to follow in the allele recovery process as only G0s that were both fertile and 
produced a shift from the wild-type melt curve in the HRMA were selected for allele 
recovery. For instance, if Gadd45 disruption is in fact lethal or leads to infertility, the 
mosaic G0s that harbor enough mutations in Gadd45 to detect in HRMA could be 
inadvertently selected to carry mild disruptions of Gadd45 or only harbor strong 
mutations in somatic cells. If the TALEN strategy is repeated, more G0s, especially those 
that have no detectable shift in HRMA melt-curve, should used for propagation. 
Alternatively, different strategies such as imprecise P-element excision could be 
attempted.   
In the future, it will also be necessary to characterize any suitable Gadd45 alleles  
in terms of any mutant phenotype they might bestow that is independent of NMD 
pathway function. Possible phenotypes that could result from Gadd45 dysfunction would 
likely be reminiscent of either Mekk1 loss of function, or defects in JNK or p38 signaling, 
such as sensitivity to high temperature or high osmolality (Inoue et al., 2001). This could 
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be done by assaying viability in response to these stresses or through molecular 
examination of MAPK pathway readouts such as p38 phosphorylation, which is reduced 
compared to wild-type in Mekk1 mutants under stress (Inoue et al., 2001). Mekk1 mutants 
are also defective in the activation of apoptosis (Kang et al., 2012), a defect that could be 
assayed in Gadd45 mutants using similar techniques to those used in Kang et al., (2012). 
Mekk1 mutants are also defective in the transcriptional response to wounding (Brun et al., 
2006), a process that activates Gadd45 and, in a Mekk1-dependent manner, upregulates 
the Turandot genes of the humoral immune system. Therefore, it would be predicted that 
Gadd45 mutants are defective in at least the transcriptional response to wounding, if not 
functionally compromised for this process.    
It will also be important in the future to examine all aspects of the NMD: Gadd45 
double null mutant phenotype. For instance, one would predict that the small clone size 
phenotype of NMD mutant tissue (Avery et al., 2011; Metzstein and Krasnow, 2006) 
would also be rescued by Gadd45 mutations. The partial rescue of the Upf214J lethal 
phase by Gadd4554C is likely not due to the cell cycle defects observed in NMD mutants, 
as cell proliferation is not required for viability in Drosophila larvae. Therefore, NMD; 
Gadd45 double mutant mitotic clones should be examined in proliferative tissue such as 
the imaginal discs or follicular epithelium, as has been done for NMD single mutants 
(Avery et al., 2011). We predict that disruption of Gadd45 will rescue this small clone 
size. If such a result is obtained, it would suggest that the pro-apoptotic signaling 
observed in NMD mutant cells is triggered by Gadd45 mRNA stabilization.  
Another experiment to test the role of Gadd45/Mekk1 activation in NMD mutants 
would be to examine genes that are upregulated by Mekk1 in response to wounding. As 
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activation of Mekk1 in NMD mutant is likely mediated through Gadd45, the expression 
levels of genes such as TotA (which is both an Mekk1 and NMD-mediated transcript) are 
predicted to be reduced in NMD/Gadd45 double mutants compared to NMD single 
mutants. Ideally, it would also be helpful to examine global mRNA levels between NMD, 
Gadd45, and NMD/Gadd45 double mutants. This would allow for the assessment of the 
proportion of secondary NMD targets that are upregulated downstream of Gadd45 
stabilization in NMD mutants. As NMD; Gadd45 double null mutants will likely be 
rescued for certain NMD defects, such an analysis would be of use in characterizing the 
cellular defects in NMD mutants. For example, the expression levels of any genes that are 
rescued by Gadd45 disruption in NMD mutants could indicate what kinds of cellular 
pathways are critically modulated in NMD mutants.  
To examine the role of MAPK activation in the NMD mutant phenotype, it will 
also be necessary to repeat the experiments described above using NMD:Gadd45 double 
mutants with NMD and JNK pathway or NMD and p38 pathway mutants. Such analysis 
would be the most direct test of the model that NMD mutants succumb to over activation 
of MAPK signaling. These experiment would be challenging for many reasons, such as 
the observation that complete disruption of JNK or p38 signaling results in a pleotropic 
phenotype that includes organismal inviability. Thus, clonal techniques would likely be 
needed to generate the desired double mutant cell populations and assess any MAPK 
mutant modulation of the clone size defect of NMD mutants.   
While consistent with our model, the interpretation of our data that Mekk1Ur36 
rescues Upf225G has limitations. Primarily, no suitable wild-type control chromosome 
exists to compare to the two Mekk1Ur36 stocks. Also, confirming the precise nature of the 
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deletion in these stocks has been challenging. gDNA from these stocks does fail to 
amplify a PCR band consistent with wild-type Mekk1, but no assay in our lab has yet 
demonstrated that our lab stocks harbor the deletion reported by Inoue et al. (2001). 
Generation of new loss-of-function alleles of Mekk1, with appropriate wild-type controls, 
would be an ideal first step toward studying the relationship between NMD and Mekk1.  
In Chapter 4 of this dissertation, we present data suggesting that function of the 
NMD pathway in neuronal tissue is sufficient to rescue the L2/L3 molting defect in Upf2 
null mutants. It is currently unclear how this result might relate to our finding that 
targeting of Gadd45 is necessary for viability beyond the second larval instar. A simple 
model would be that in NMD mutants, Gadd45 upregulation specifically in neuronal 
tissue is lethal. However, expression of a UAS:Gadd45 cDNA using the same GAL4 
drivers that rescue Upf214J does not result in any lethality (data not shown), whereas 
global overexpression of the same cDNA is lethal (Peretz et al., 2007). These results 
suggest that upregulation of Gadd45 in the CNS or neuronal tissue is not the cause of 
inviability in NMD mutants. One speculative possibility is related to the model described 
in Chapter 4 that states that the rescue of Upf214J in the CNS is due to a gain-of-function 
phenotype that does not require that NMD be essential in the CNS. In this model, NMD 
defects in nonneuronal tissue disrupt the L2/L3 molt, and activation of NMD in the CNS 
drives a second pathway (possibly related to release of PTTH from neuroendocrine cells) 
that drives molting. Our observations that Gadd45 overexpression in the CNS is not 
incompatible with viability fit into this model, as Gadd45 need not be critically targeted 
in the CNS. Instead, we predict that NMD mutants succumb to Gadd45 overexpression in 
multiple, nonneuronal cell types, and expression of NMD in the CNS activates a non-
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Gadd45 mediated pro-molting pathway. The model could be supported by experiments 
that demonstrate that NMD function is not required in neuronal tissue. 
Lastly, it is likely that Gadd45/Mekk1 does not mediate the entire phenotype of 
NMD loss-of-function mutants. In the future, continued analysis of our 24 critical target 
genes could yield further insights into the physiological and developmental roles of NMD 
function. For instance, a systematic approach could be used to analyze any functional 
consequences to the targeting of these genes by the NMD pathway. RNAi could be used 
to ask if individually inhibiting the function of the 23 remaining genes in a NMD-mutant 
background can rescue some aspect of NMD function. Additionally, part of the logic for 
using a hypomorphic allele of Upf2 in the deficiency rescue screen was to identify 
regions that can rescue different aspects of the NMD mutant phenotype. Most of our 
transcriptome analysis was focused on late larval stages, but it is known that NMD acts 
earlier in development and is predicted to function later in development as well. Thus, 
continued analysis of the genes identified by this screen could aid in our understanding of 
NMD at all times in development and in all environmental conditions. For instance, the 
deficiency rescue screen identified a region around the gene Arc1 that we believe could 
be an important indirect target of NMD function. Xrp1, a critical target gene, is also 
uncovered by the same deficiencies that uncover Mekk1 and rescue Upf225G. While 
Mekk1 likely plays an important role in NMD-mediated gene regulation, this does not 
preclude Xrp1 also having important NMD-related functions. Activation of Xrp1 leads to 
growth arrest (Akdemir et al., 2007), as does NMD loss of function, suggesting these 
genes could also function downstream of NMD, possibly along with Gadd45, to initiate 
growth arrest and apoptosis when NMD is inhibited. 
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In summary, we have presented data that suggest that NMD has important 
functions over the course of Drosophila development. Our data support a model similar 
to the Swiss Army Knife model of critical NMD function, where NMD critically 
regulates a small number of direct target genes, one of which is Gadd45. Direct negative 
regulation of Gadd45 is critical for suppression of Mekk1/MAPK signaling and 
development past the L2/L3 larval molt. Continued analysis of this model, as well as of 
the 23 remaining critical target genes, will yield further insights into NMD function.                     
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